☰

cached image

Craig Michael Horbinski, MD, University of Rochester, PhD, University of Rochester - Publications

Affiliations: 
2015 Pathology and Laboratory Medicine University of Kentucky, Lexington, KY 
 2015- Northwestern University, Evanston, IL 
Area:
Neuropathology, molecucular neuro-oncology, teleneuropathology
Website:
http://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=33419
Tree Info Grants Similar researchers PubMed Report error

151/307 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Arrieta VA, Duerinck J, Burdett KB, Habashy KJ, Geens W, Gould A, Schwarze JK, Dmello C, Kim KS, Saganty R, Chen L, Moscona A, McCord M, Lee-Chang C, Horbinski CM, et al. ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-Guided Analysis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37939133 DOI: 10.1158/1078-0432.CCR-23-1889  0.722
2023 McCord M, Jamshidi P, Thirunavu V, Santana-Santos L, Vormittag-Nocito E, Dittman D, Parker S, Baczkowski J, Jennings L, Walshon J, McCortney K, Galbraith K, Zhang H, Lukas RV, Stupp R, ... ... Horbinski C, et al. Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results. Acta Neuropathologica Communications. 11: 175. PMID 37919784 DOI: 10.1186/s40478-023-01680-0  0.737
2023 Johnson M, Bell A, Lauing KL, Ladomersky E, Zhai L, Penco-Campillo M, Shah Y, Mauer E, Xiu J, Nicolaides T, Drumm M, McCortney K, Elemento O, Kim M, Bommi P, ... ... Horbinski C, et al. Advanced age in humans and mouse models of glioblastoma show decreased survival from extratumoral influence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37725593 DOI: 10.1158/1078-0432.CCR-23-0834  0.714
2023 Budhiraja S, Najem H, Tripathi S, Wadhawani NR, Horbinski C, McCord M, Lenzen AC, Heimberger AB, DeCuypere M. Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review. Cancers. 15. PMID 37509316 DOI: 10.3390/cancers15143655  0.73
2023 Drumm M, Wang W, Sears TK, Bell-Burdett K, Javier R, Cotton KY, Webb BT, Byrne KT, Unruh D, Thirunavu V, Walshon J, Steffens A, McCortney K, Lukas RV, Phillips JJ, ... ... Horbinski C, et al. Postoperative risk of IDH mutant glioma-associated seizures and their potential management with IDH mutant inhibitors. The Journal of Clinical Investigation. PMID 37104042 DOI: 10.1172/JCI168035  0.763
2023 Jamshidi P, McCord M, Galbraith K, Santana-Santos L, Jennings LJ, Snuderl M, Horbinski C. Variant allelic frequency of driver mutations predicts success of genomic DNA methylation classification in central nervous system tumors. Acta Neuropathologica. 145: 365-367. PMID 36700952 DOI: 10.1007/s00401-023-02542-8  0.729
2022 McCord M, Bartom E, Burdett K, Baran A, Eckerdt FD, Balyasnikova IV, McCortney K, Sears T, Cheng SY, Sarkaria JN, Stupp R, Heimberger AB, Ahmed A, James CD, Horbinski C. Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts. Cancers. 14. PMID 36428586 DOI: 10.3390/cancers14225494  0.781
2022 Burdett KB, Unruh D, Drumm M, Steffens A, Lamano JB, Judkins J, Schwartz M, Javier R, Amidei C, Lipp ES, Peters KB, Lai A, Eldred BSC, Heimberger AB, McCortney K, ... ... Horbinski C, et al. Determining venous thromboembolism risk in patients with adult-type diffuse glioma. Blood. PMID 36399711 DOI: 10.1182/blood.2022017858  0.727
2022 Cimino PJ, Ketchum C, Turakulov R, Singh O, Abdullaev Z, Giannini C, Pytel P, Lopez GY, Colman H, Nasrallah MP, Santi M, Fernandes IL, Nirschl J, Dahiya S, Neill S, ... ... Horbinski C, et al. Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. Acta Neuropathologica. PMID 36271929 DOI: 10.1007/s00401-022-02513-5  0.698
2022 Santana-Santos L, Kam KL, Dittmann D, De Vito S, McCord M, Jamshidi P, Fowler H, Wang X, Aalsburg AM, Brat DJ, Horbinski C, Jennings LJ. Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors. The Journal of Molecular Diagnostics : Jmd. PMID 35605901 DOI: 10.1016/j.jmoldx.2022.04.009  0.732
2022 Smith HL, Wadhwani N, Horbinski C. Major Features of the 2021 WHO Classification of CNS Tumors. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 35578106 DOI: 10.1007/s13311-022-01249-0  0.521
2022 Arrieta VA, Chen AX, Kane JR, Kang SJ, Kassab C, Dmello C, Zhao J, Burdett KB, Upadhyayula PS, Lee-Chang C, Shilati J, Jaishankar D, Chen L, Gould A, Zhang D, ... ... Horbinski C, et al. Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma. Nature Cancer. PMID 35149861 DOI: 10.1038/s43018-022-00343-8  0.709
2022 Javier R, Wang W, Drumm M, McCortney K, Sarkaria JN, Horbinski C. The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma. Plos One. 17: e0257725. PMID 35134075 DOI: 10.1371/journal.pone.0257725  0.723
2022 Drumm M, Templer JW, Tate M, Jennings L, Horbinski C. Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutation. Neuro-Oncology Advances. 4: vdac004. PMID 35128400 DOI: 10.1093/noajnl/vdac004  0.69
2022 Pratt D, Abdullaev Z, Papanicolau-Sengos A, Ketchum C, Panneer Selvam P, Chung HJ, Lee I, Raffeld M, Gilbert MR, Armstrong TS, Pytel P, Borys E, Klonoski JM, McCord M, Horbinski C, et al. High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta Neuropathologica. PMID 35103816 DOI: 10.1007/s00401-022-02404-9  0.762
2021 Arrieta VA, Chen AX, Kane JR, Kang SJ, Kassab C, Dmello C, Zhao J, Burdett KB, Upadhyayula PS, Lee-Chang C, Shilati J, Jaishankar D, Chen L, Gould A, Zhang D, ... ... Horbinski C, et al. ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma. Nature Cancer. 2: 1372-1386. PMID 35121903 DOI: 10.1038/s43018-021-00260-2  0.737
2021 Sears TK, Horbinski CM, Woolard KD. IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat. Journal of Neuro-Oncology. PMID 34424450 DOI: 10.1007/s11060-021-03829-0  0.741
2021 McCord M, Lukas RV, Amidei C, Demars N, Gelb A, Buck J, Sachdev S, Feldman A, Tate M, Dixit K, Brat DJ, Jennings L, Horbinski C. Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient. Neuro-Oncology Advances. 3: vdab045. PMID 34250480 DOI: 10.1093/noajnl/vdab045  0.7
2020 Kanojia D, Panek WK, Cordero A, Fares J, Xiao A, Savchuk S, Kumar K, Xiao T, Pituch KC, Miska J, Zhang P, Kam KL, Horbinski C, Balyasnikova IV, Ahmed AU, et al. BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine. Science Translational Medicine. 12. PMID 32848091 DOI: 10.1126/Scitranslmed.Aax2879  0.304
2020 Torre M, Vasudevaraja V, Serrano J, DeLorenzo M, Malinowski S, Blandin AF, Pages M, Ligon AH, Dong F, Meredith DM, Nasrallah MP, Horbinski C, Dahiya S, Ligon KL, Santi M, et al. Molecular and clinicopathologic features of gliomas harboring NTRK fusions. Acta Neuropathologica Communications. 8: 107. PMID 32665022 DOI: 10.1186/S40478-020-00980-Z  0.349
2020 Unruh D, Horbinski C. Beyond thrombosis: the impact of tissue factor signaling in cancer. Journal of Hematology & Oncology. 13: 93. PMID 32665005 DOI: 10.1186/S13045-020-00932-Z  0.303
2020 Nassiri F, Chakravarthy A, Feng S, Shen SY, Nejad R, Zuccato JA, Voisin MR, Patil V, Horbinski C, Aldape K, Zadeh G, De Carvalho DD. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes. Nature Medicine. PMID 32572265 DOI: 10.1038/S41591-020-0932-2  0.346
2020 Cheng X, Geng F, Pan M, Wu X, Zhong Y, Wang C, Tian Z, Cheng C, Zhang R, Puduvalli V, Horbinski C, Mo X, Han X, Chakravarti A, Guo D. Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress. Cell Metabolism. PMID 32559414 DOI: 10.1016/J.Cmet.2020.06.002  0.309
2020 Ladomersky E, Zhai L, Lauing KL, Bell A, Xu J, Kocherginsky M, Zhang B, Wu JD, Podojil JR, Platanias LC, Mochizuki AY, Prins RM, Kumthekar P, Raizer J, Dixit K, ... ... Horbinski C, et al. Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32546647 DOI: 10.1158/1078-0432.Ccr-19-3874  0.339
2020 Kam KL, Appin CL, Mao Q, Ikegami S, Lukas RV, Nikiforova MN, Roy S, Brat DJ, Horbinski C. Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas? Journal of Neuropathology and Experimental Neurology. PMID 32483596 DOI: 10.1093/Jnen/Nlaa044  0.37
2020 Feldman AZ, Jennings LJ, Wadhwani NR, Brat DJ, Horbinski CM. The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results. Current Neurology and Neuroscience Reports. 20: 23. PMID 32445025 DOI: 10.1007/S11910-020-01041-7  0.32
2020 Kane JR, Zhao J, Tsujiuchi T, Laffleur B, Arrieta VA, Mahajan A, Rao G, Mela A, Dmello C, Chen L, Zhang DY, Gonzalez-Buendia E, Lee-Chang C, Xiao T, Rothschild G, ... ... Horbinski C, et al. CD8 T-cell-mediated immunoediting influences genomic evolution and immune evasion in murine gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32430477 DOI: 10.1158/1078-0432.Ccr-19-3104  0.339
2020 Wen PY, Weller M, Lee EQ, Alexander BA, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, ... Horbinski C, et al. Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions. Neuro-Oncology. PMID 32328653 DOI: 10.1093/Neuonc/Noaa106  0.332
2020 Bayik D, Zhou Y, Park C, Hong C, Vail D, Silver DJ, Lauko A, Roversi G, Watson DC, Lo A, Alban TJ, McGraw M, Sorensen M, Grabowski MM, Otvos B, ... ... Horbinski C, et al. Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner. Cancer Discovery. PMID 32300059 DOI: 10.1158/2159-8290.Cd-19-1355  0.34
2020 Sastry NG, Wan X, Huang T, Alvarez AA, Pangeni RP, Song X, James CD, Horbinski CM, Brennan CW, Nakano I, Hu B, Cheng SY. LY6K Promotes Glioblastoma Tumorigenicity via CAV-1-Mediated ERK1/2 Signaling Enhancement. Neuro-Oncology. PMID 32055849 DOI: 10.1093/Neuonc/Noaa032  0.355
2020 McCord M, Steffens A, Javier R, Kam KL, McCortney K, Horbinski C. The efficacy of DNA mismatch repair enzyme immunohistochemistry as a screening test for hypermutated gliomas. Acta Neuropathologica Communications. 8: 15. PMID 32051040 DOI: 10.1186/S40478-020-0892-2  0.77
2020 Drumm MR, Dixit KS, Grimm S, Kumthekar P, Lukas RV, Raizer JJ, Stupp R, Chheda MG, Kam KL, McCord M, Sachdev S, Kruser T, Steffens A, Javier R, McCortney K, ... Horbinski C, et al. Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas. Neuro-Oncology. 22: 470-479. PMID 31711239 DOI: 10.1093/Neuonc/Noz216  0.762
2020 Cooley L, Kam K, Horbinski C, Sukhanova M, Gener M, Ginn K, Lu X. 7. ROS1-GOPC gene fusion characterizes a minor subset of brain tumors Cancer Genetics and Cytogenetics. 244: 3. DOI: 10.1016/J.Cancergen.2020.04.011  0.322
2019 Haider AS, van den Bent M, Wen PY, Vogelbaum MA, Chang S, Canoll PD, Horbinski CM, Huse JT. Towards a standard pathological and molecular characterization of recurrent glioma in adults: a RANO effort. Neuro-Oncology. PMID 31844891 DOI: 10.1093/Neuonc/Noz233  0.352
2019 Lukas RV, Wainwright DA, Horbinski CM, Iwamoto FM, Sonabend AM. Immunotherapy Against Gliomas: is the Breakthrough Near? Drugs. PMID 31598900 DOI: 10.1007/S40265-019-01203-Z  0.304
2019 Lee-Chang C, Rashidi A, Miska J, Zhang P, Pituch KC, Hou D, Xiao T, Fischietti M, Kang SJ, Appin CL, Horbinski C, Platanias LC, Lopez-Rosas A, Han Y, Balyasnikova IV, et al. Myeloid-derived suppressive cells promote B cell-mediated immunosuppression via transfer of PD-L1 in glioblastoma. Cancer Immunology Research. PMID 31530559 DOI: 10.1158/2326-6066.Cir-19-0240  0.321
2019 Song X, Wan X, Huang T, Zeng C, Sastry N, Wu B, James CD, Horbinski C, Nakano I, Zhang W, Hu B, Cheng SY. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes. Cancer Research. PMID 31462429 DOI: 10.1158/0008-5472.Can-19-1504  0.346
2019 Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O, Ikeda Y, Warren M, Sakamoto N, Kitahara S, Yoshino H, Yamashita D, Sumita K, Wolfe K, Lange L, ... ... Horbinski C, et al. IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Nature Cell Biology. 21: 1003-1014. PMID 31371825 DOI: 10.1038/S41556-019-0363-9  0.322
2019 Roy S, Agnihotri S, El Hallani S, Ernst WL, Wald AI, Santana Dos Santos L, Hamilton RL, Horbinski CM, Wadhwani NR, Born DE, Pollack IF, Nikiforov YE, Nikiforova MN. Clinical Utility of GlioSeq Next-Generation Sequencing Test in Pediatric and Young Adult Patients With Brain Tumors. Journal of Neuropathology and Experimental Neurology. PMID 31298284 DOI: 10.1093/Jnen/Nlz055  0.559
2019 Horbinski C, Ligon KL, Brastianos P, Huse JT, Venere M, Chang S, Buckner J, Cloughesy T, Jenkins RB, Giannini C, Nabors LB, Wen PY, Aldape KJ, Lukas RV, Galanis E, et al. The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients. Neuro-Oncology. PMID 31276167 DOI: 10.1093/Neuonc/Noz119  0.359
2019 Unruh D, Zewde M, Buss A, Drumm MR, Tran AN, Scholtens DM, Horbinski C. Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers. Scientific Reports. 9: 8946. PMID 31222125 DOI: 10.1038/S41598-019-45346-1  0.739
2019 Chen H, Thomas C, Munoz FA, Alexandrescu S, Horbinski CM, Olar A, McGuone D, Camelo-Piragua S, Wang L, Pentsova E, Phillips J, Aldape K, Chen W, Iafrate AJ, Chi AS, et al. Polysomy is associated with poor outcome in 1p19q co-deleted oligodendroglial tumors. Neuro-Oncology. PMID 31140557 DOI: 10.1093/Neuonc/Noz098  0.35
2019 Qi J, Esfahani DR, Huang T, Ozark P, Bartom E, Hashizume R, Bonner ER, An S, Horbinski CM, James CD, Saratsis AM. Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease. Acta Neuropathologica Communications. 7: 75. PMID 31092287 DOI: 10.1186/S40478-019-0727-1  0.4
2019 Lamano JB, Quaggin-Smith JA, Horbinski CM, Tate MC, Grimm SA, Kumthekar PU, Bloch O. Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 30948314 DOI: 10.1016/J.Jocn.2019.03.051  0.374
2019 Hasan T, Caragher SP, Shireman JM, Park CH, Atashi F, Baisiwala S, Lee G, Guo D, Wang JY, Dey M, Wu M, Lesniak MS, Horbinski CM, James CD, Ahmed AU. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma. Cell Death & Disease. 10: 292. PMID 30926789 DOI: 10.1038/S41419-019-1387-6  0.346
2019 Eckerdt F, Bell JB, Beauchamp EM, Clymer J, Blyth GT, Kosciuczuk EM, Ma Q, Chen DZ, Horbinski C, Goldman S, Munshi HG, Hashizume R, Platanias LC. Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in Medulloblastoma. Molecular Cancer Research : McR. PMID 30842251 DOI: 10.1158/1541-7786.Mcr-18-1193  0.387
2019 Lamano JB, Lamano JB, Li YD, DiDomenico JD, Choy W, Veliceasa D, Oyon DE, Fakurnejad S, Ampie L, Kesavabhotla K, Kaur R, Kaur G, Biyashev D, Unruh D, Horbinski C, et al. Glioblastoma-Derived IL-6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30824583 DOI: 10.1158/1078-0432.Ccr-18-2402  0.307
2019 Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, Bordbar D, Shan D, Samanamud J, Mahajan A, Filip I, Orenbuch R, Goetz M, Yamaguchi JT, Cloney M, ... Horbinski C, et al. Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nature Medicine. PMID 30742119 DOI: 10.1038/S41591-019-0349-Y  0.361
2019 Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H, Perry A, Sahm F, Sloan A, Von Deimling A, Wen PY, et al. Molecular and translational advances in meningiomas. Neuro-Oncology. 21: i4-i17. PMID 30649490 DOI: 10.1093/Neuonc/Noy178  0.339
2019 May JL, Kouri FM, Hurley LA, Liu J, Tommasini-Ghelfi S, Ji Y, Gao P, Calvert AE, Lee A, Chandel NS, Davuluri RV, Horbinski CM, Locasale JW, Stegh AH. IDH3α regulates one-carbon metabolism in glioblastoma. Science Advances. 5: eaat0456. PMID 30613765 DOI: 10.1126/Sciadv.Aat0456  0.31
2019 Tran A, Unruh D, Mirkov S, Horbinski C. Stem-06. Tissue Factor Signaling In Glioblastoma Tumor-Initiating Cells Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.980  0.315
2019 Robert Kane J, Zhao J, Tsujiuchi T, Laffleur B, Mahajan A, Rao G, Mela A, Dmello C, Arrieta VA, Chen L, Zhang DY, Lee-Chang C, Xiao T, Rothschild G, Basu U, ... Horbinski C, et al. IMMU-42. CD8+ T-CELLS MEDIATE IMMUNOEDITING, AND INFLUENCE GENOTYPE, TUMOR ONCOGENIC PATHWAYS AND MICROENVIRONMENT DURING PROGRESSION OF MURINE GLIOMAS Neuro-Oncology. 21: vi128-vi128. DOI: 10.1093/Neuonc/Noz175.534  0.343
2019 Wang Y, Horbinski C, James C, Sathiaseelan V, Kalapurakal J. TMOD-20. COMBINING TARGETED INHIBITOR AND RADIOTHERAPY IN TREATING ANAPLASTIC MENINGIOMA Neuro-Oncology. 21: vi266-vi267. DOI: 10.1093/Neuonc/Noz175.1119  0.356
2019 James C, Horbinski C, Bartom E, Burdett K, Scholtens D, Ahmed A. OS12.6 Intracranial GBM PDX Mutations Induced by Temozolomide Treatment Neuro-Oncology. 21: iii23-iii23. DOI: 10.1093/Neuonc/Noz126.078  0.377
2018 Huang T, Garcia R, Qi J, Lulla R, Horbinski C, Behdad A, Wadhwani N, Shilatifard A, James C, Saratsis A. Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes. Oncotarget. 9: 37112-37124. PMID 30647848 DOI: 10.18632/Oncotarget.26430  0.352
2018 Jester R, Znoyko I, Garnovskaya M, Rozier JN, Kegl R, Patel S, Tran T, Abedalthagafi M, Horbinski CM, Richardson M, Wolff DJ, Lapadat R, Moore W, Rodriguez FJ, Mull J, et al. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls. Acta Neuropathologica Communications. 6: 107. PMID 30340515 DOI: 10.1186/S40478-018-0607-0  0.329
2018 Unruh D, Mirkov S, Wray B, Drumm M, Lamano J, Li YD, Haider QF, Javier R, McCortney K, Saratsis AM, Scholtens DM, Sarkaria JN, James CD, Horbinski C. Methylation-dependent Tissue Factor suppression contributes to the reduced malignancy of IDH1 mutant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30266764 DOI: 10.1158/1078-0432.Ccr-18-1222  0.738
2018 Koehler JW, Miller AD, Miller CR, Porter B, Aldape K, Beck J, Brat D, Cornax I, Corps K, Frank C, Giannini C, Horbinski C, Huse JT, O'Sullivan MG, Rissi DR, et al. A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma. Journal of Neuropathology and Experimental Neurology. PMID 30239918 DOI: 10.1093/Jnen/Nly085  0.353
2018 Hussain F, Horbinski CM, Chmura SJ, Yamini B, Lukas RV. Response to BRAF/MEK Inhibition After Progression With BRAF Inhibition in a Patient With Anaplastic Pleomorphic Xanthoastrocytoma. The Neurologist. 23: 163-166. PMID 30169370 DOI: 10.1097/Nrl.0000000000000194  0.365
2018 Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. An overview of meningiomas. Future Oncology (London, England). PMID 30084265 DOI: 10.2217/Fon-2018-0006  0.323
2018 Linninger A, Hartung GA, Liu BP, Mirkov S, Tangen K, Lukas RV, Unruh D, James CD, Sarkaria JN, Horbinski C. Modeling the diffusion of D-2-hydroxyglutarate from IDH1 mutant gliomas in the central nervous system. Neuro-Oncology. PMID 29660019 DOI: 10.1093/Neuonc/Noy051  0.322
2018 Aldape K, Amin SB, Ashley DM, Barnholtz-Sloan JS, Bates AJ, Beroukhim R, Bock C, Brat DJ, Claus EB, Costello JF, de Groot JF, Finocchiaro G, French PJ, Gan HK, Griffith B, ... ... Horbinski C, et al. Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. Neuro-Oncology. PMID 29432615 DOI: 10.1093/Neuonc/Noy020  0.362
2018 Huang T, Kim CK, Alvarez AA, Pangeni RP, Wan X, song x, shi T, Yongyong Y, Sastry N, Horbinski C, Lu S, Stupp R, Kessler J, Nishikawa R, Nakano I, et al. Abstract 1122: MST4 phosphorylation of ATG4B regulates autophagic activity, tumorigenicity, and radio resistance in glioblastoma Cancer Research. 78: 1122-1122. DOI: 10.1158/1538-7445.Am2018-1122  0.381
2017 Huang T, Kim CK, Alvarez AA, Pangeni RP, Wan X, Song X, Shi T, Yang Y, Sastry N, Horbinski CM, Lu S, Stupp R, Kessler JA, Nishikawa R, Nakano I, et al. MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma. Cancer Cell. 32: 840-855.e8. PMID 29232556 DOI: 10.1016/J.Ccell.2017.11.005  0.372
2017 Bell JB, Eckerdt F, Dhruv H, Finlay D, Peng S, Kim S, Kroczynska B, Beauchamp E, Alley K, Clymer J, Goldman S, Cheng SY, James CD, Nakano I, Horbinski C, et al. Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy is Regulated by MNK1 and mRNA Translation. Molecular Cancer Research : McR. PMID 29042487 DOI: 10.1158/1541-7786.Mcr-17-0397  0.355
2017 Zhai L, Ladomersky E, Lauing KL, Wu M, Genet M, Gritsina G, Győrffy B, Brastianos PK, Binder D, Sosman JA, Giles FJ, James CD, Horbinski C, Stupp R, Wainwright DA. Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28751450 DOI: 10.1158/1078-0432.Ccr-17-0120  0.338
2017 Panwalkar P, Clark J, Ramaswamy V, Hawes D, Yang F, Dunham C, Yip S, Hukin J, Sun Y, Schipper MJ, Chavez L, Margol A, Pekmezci M, Chung C, Banda A, ... ... Horbinski CM, et al. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathologica. PMID 28733933 DOI: 10.1007/S00401-017-1752-4  0.379
2017 Miller TE, Liau BB, Wallace LC, Morton AR, Xie Q, Dixit D, Factor DC, Kim LJY, Morrow JJ, Wu Q, Mack SC, Hubert CG, Gillespie SM, Flavahan WA, Hoffmann T, ... ... Horbinski CM, et al. Transcription elongation factors represent in vivo cancer dependencies in glioblastoma. Nature. PMID 28678782 DOI: 10.1038/Nature23000  0.316
2017 Calvert AE, Chalastanis A, Wu Y, Hurley LA, Kouri FM, Bi Y, Kachman M, May JL, Bartom E, Hua Y, Mishra RK, Schiltz GE, Dubrovskyi O, Mazar AP, Peter ME, ... ... Horbinski C, et al. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation. Cell Reports. 19: 1858-1873. PMID 28564604 DOI: 10.1016/J.Celrep.2017.05.014  0.386
2017 Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, Tomita T, James CD, Shilatifard A, Saratsis AM. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathologica Communications. 5: 28. PMID 28416018 DOI: 10.1186/S40478-017-0436-6  0.376
2017 Chen H, Judkins J, Thomas C, Wu M, Khoury L, Benjamin CG, Pacione D, Golfinos JG, Kumthekar P, Ghamsari F, Chen L, Lein P, Chetkovich DM, Snuderl M, Horbinski C. Mutant IDH1 and seizures in patients with glioma. Neurology. PMID 28404805 DOI: 10.1212/Wnl.0000000000003911  0.551
2017 Wainwright DA, Horbinski CM, Hashizume R, James CD. Therapeutic Hypothesis Testing With Rodent Brain Tumor Models. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28321824 DOI: 10.1007/S13311-017-0523-1  0.353
2017 Huang B, Luo A, Durbin EB, Lycan E, Tucker T, Chen Q, Horbinski C, Villano JL. Incidence of CNS tumors in Appalachian children. Journal of Neuro-Oncology. PMID 28285334 DOI: 10.1007/S11060-017-2403-2  0.311
2017 Piunti A, Hashizume R, Morgan MA, Bartom ET, Horbinski CM, Marshall SA, Rendleman EJ, Ma Q, Takahashi YH, Woodfin AR, Misharin AV, Abshiru NA, Lulla RR, Saratsis AM, Kelleher NL, et al. Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nature Medicine. PMID 28263307 DOI: 10.1038/Nm.4296  0.396
2017 Wicker CA, Scott TL, Suganya R, Arnold SM, Brill YM, Horbinski CM, Napier D, Valentino J, Kudrimoti MR, Yu G, Izumi T. Abstract 4142: Regulation of tumor suppressor decorin by APE1 in head and neck squamous cell carcinoma Cancer Research. 77: 4142-4142. DOI: 10.1158/1538-7445.Am2017-4142  0.362
2017 Unruh D, Mirkov S, James CD, Horbinski C. Abstract 1345: Mutant IDH1 and tissue factor in gliomas Cancer Research. 77: 1345-1345. DOI: 10.1158/1538-7445.Am2017-1345  0.39
2017 Oh S, Vigneswaran K, Schniederjan M, Horbinski C, Hambardzumyan D, Becher O, Kenney A, Read R. PDTM-35. THERAPEUTIC RELEVANCE OF YAP/TAZ ACTIVITY IN PEDIATRIC HIGH-GRADE GLIOMA. Neuro-Oncology. 19: vi197-vi197. DOI: 10.1093/Neuonc/Nox168.798  0.313
2017 Zhai L, Ladomersky E, Lauing K, Wu M, Genet M, Gritsina G, Gyorffy B, Brastianos P, Binder D, Sosman J, Giles F, James CD, Horbinski CM, Stupp R, Wainwright D. IMMU-66. IDO1 EXPRESSION STRATIFIES PATIENT SURVIVAL AND IS REGULATED BY TUMOR INFILTRATING T CELLS IN HUMAN GLIOBLASTOMA Neuro-Oncology. 19: vi127-vi127. DOI: 10.1093/Neuonc/Nox168.523  0.351
2017 James CD, Stupp R, Lukas RV, Kalapurakal JA, Akhtar-Zaidi B, Horbinski CM. TMOD-17. BRAIN TUMOR PATIENT DERIVED XENOGRAFT FROM LUNG TUMOR METASTASIS: ESTABLISHMENT AND CHARACTERIZATION Neuro-Oncology. 19: vi258-vi258. DOI: 10.1093/Neuonc/Nox168.1055  0.341
2017 Ahmed AU, Horbinski CM, Stupp R, Lesniak MS, James CD. P08.01 Tumor cell subpopulation changes during intracranial glioblastoma patient derived xenograft recurrence following radiation, temozolomide, or combination therapy Neuro-Oncology. 19: iii53-iii53. DOI: 10.1093/Neuonc/Nox036.191  0.357
2017 Chen H, Judkins J, Ghamsari F, Lein P, Horbinski C. OS05.1 The D-2-hydroxyglutarate product of mutant IDH1 induces synchronized neuronal firing via NMDA receptor activation Neuro-Oncology. 19: iii8-iii9. DOI: 10.1093/Neuonc/Nox036.028  0.492
2016 Unruh D, Schwarze SR, Khoury L, Thomas C, Wu M, Chen L, Chen R, Liu Y, Schwartz MA, Amidei C, Kumthekar P, Benjamin CG, Song K, Dawson C, Rispoli JM, ... ... Horbinski C, et al. Mutant IDH1 and thrombosis in gliomas. Acta Neuropathologica. PMID 27664011 DOI: 10.1007/S00401-016-1620-7  0.38
2016 Chang AL, Miska J, Wainwright DA, Dey M, Rivetta CV, Yu D, Kanojia D, Pituch KC, Qiao J, Pytel P, Han Y, Wu M, Zhang L, Horbinski C, Ahmed AU, et al. CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells. Cancer Research. PMID 27530322 DOI: 10.1158/0008-5472.Can-16-0144  0.366
2016 Hashizume R, Zhang A, Mueller S, Prados MD, Lulla RR, Goldman S, Saratsis AM, Mazar AP, Stegh AH, Cheng SY, Horbinski C, Haas-Kogan DA, Sarkaria JN, Waldman T, James CD. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth. Neuro-Oncology. PMID 27370397 DOI: 10.1093/Neuonc/Now106  0.367
2016 Bell JB, Eckerdt F, Alley K, Magnusson LP, Hussain H, Bi Y, Arslan AD, Clymer J, Alvarez AA, Goldman S, Cheng SY, Nakano I, Horbinski C, Davuluri RV, James CD, et al. MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma. Molecular Cancer Research : McR. PMID 27364770 DOI: 10.1158/1541-7786.Mcr-16-0172  0.402
2016 Scott TL, Wicker CA, Suganya R, Dhar B, Pittman T, Horbinski C, Izumi T. Polyubiquitination of apurinic/apyrimidinic endonuclease 1 by Parkin. Molecular Carcinogenesis. PMID 27148961 DOI: 10.1002/Mc.22495  0.306
2016 Zhai L, Genet M, Ladomersky E, Lauing K, Wu M, Binder D, Kim L, Rich J, Horbinski C, James CD, Sosman JA, Bloch O, Wainwright DA. Abstract A064: IDO1 expression stratifies glioblastoma patient survival and correlates with dominantly immunosuppressive pathways Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A064  0.313
2016 Zhou P, Erfani S, Segal R, Horbinski C, Yang XH. Abstract 5092: CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion Cancer Research. 76: 5092-5092. DOI: 10.1158/1538-7445.Am2016-5092  0.369
2016 Chen H, Judkins J, Ghamsari F, Lein P, Horbinski C. QLIF-03. MUTANT IDH1 PROMOTES TUMOR-ASSOCIATED EPILEPSY IN GLIOMA PATIENTS Neuro-Oncology. 18: vi156-vi156. DOI: 10.1093/Neuonc/Now212.649  0.583
2016 Chen H, Thomas C, Munoz FA, Alexandrescu S, Horbinski C, Olar A, McGuone D, Camelo-Piragua S, Wang L, Pentsova E, Phillips J, Aldape K, Iafrate AJ, Golfinos J, Chi A, et al. MPTH-34. THE PROGNOSTIC VALUE OF POLYSOMY IN OLIGODENDROGLIAL TUMORS Neuro-Oncology. 18: vi113-vi113. DOI: 10.1093/Neuonc/Now212.471  0.326
2015 Nikiforova MN, Wald AI, Melan MA, Roy S, Zhong S, Hamilton RL, Lieberman FS, Drappatz J, Amankulor NM, Pollack IF, Nikiforov YE, Horbinski C. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. Neuro-Oncology. PMID 26681766 DOI: 10.1093/Neuonc/Nov289  0.54
2015 Zhou P, Erfani S, Liu Z, Jia C, Chen Y, Xu B, Deng X, Alfaro JE, Chen L, Napier D, Lu M, Huang JA, Liu C, Thibault O, Segal R, ... ... Horbinski C, et al. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion. Oncotarget. PMID 26377974 DOI: 10.18632/Oncotarget.4896  0.384
2015 Venere M, Horbinski C, Crish JF, Jin X, Vasanji A, Major J, Burrows AC, Chang C, Prokop J, Wu Q, Sims PA, Canoll P, Summers MK, Rosenfeld SS, Rich JN. The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma. Science Translational Medicine. 7: 304ra143. PMID 26355032 DOI: 10.1126/Scitranslmed.Aac6762  0.357
2015 Lee DH, Zhang Y, Kassam AB, Park MJ, Gardner P, Prevedello D, Henry S, Horbinski C, Beumer JH, Tawbi H, Williams BJ, Shaffrey ME, Egorin MJ, Abounader R, Park DM. Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma. Plos One. 10: e0134426. PMID 26247786 DOI: 10.1371/Journal.Pone.0134426  0.359
2015 Lee TJ, Haque F, Shu D, Yoo JY, Li H, Yokel RA, Horbinski C, Kim TH, Kim SH, Kwon CH, Nakano I, Kaur B, Guo P, Croce CM. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget. 6: 14766-76. PMID 25885522 DOI: 10.18632/Oncotarget.3632  0.315
2015 Xie Q, Wu Q, Horbinski CM, Flavahan WA, Yang K, Zhou W, Dombrowski SM, Huang Z, Fang X, Shi Y, Ferguson AN, Kashatus DF, Bao S, Rich JN. Mitochondrial control by DRP1 in brain tumor initiating cells. Nature Neuroscience. 18: 501-10. PMID 25730670 DOI: 10.1038/Nn.3960  0.333
2015 Massarweh SA, Chmielecki J, Sun J, Stewart RL, Dressler EVM, Kadamyan V, Chambers MD, Horbinski C, Mehdi M, Black EP, Romond EH. Effect of mutations in distinct components of the PI3K/AKT/mTOR pathway on sensitivity to endocrine therapy in estrogen receptor (ER)-positive breast cancer. Journal of Clinical Oncology. 33: 532-532. DOI: 10.1200/Jco.2015.33.15_Suppl.532  0.352
2015 Schwarze S, Khoury L, Thomas C, Benjamin C, Chen R, Chen L, Liu Y, Song K, Dawson C, Pacione D, Zagzag D, McIntyre T, Snuderl M, Horbinski C. TMIC-13MUTANTIDH1/2SUPPRESSES LOCAL AND SYSTEMIC THROMBOSIS IN GLIOMA PATIENTS Neuro-Oncology. 17: v217.5-v217. DOI: 10.1093/Neuonc/Nov236.13  0.375
2014 Liu Y, Gilbert MR, Kyprianou N, Rangnekar VM, Horbinski C. The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells. Acta Neuropathologica. 128: 723-32. PMID 25135281 DOI: 10.1007/S00401-014-1334-7  0.41
2014 Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1985-96. PMID 25053711 DOI: 10.1158/1055-9965.Epi-14-0275  0.353
2014 Chen L, Voronovich Z, Clark K, Hands I, Mannas J, Walsh M, Nikiforova MN, Durbin EB, Weiss H, Horbinski C. Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma. Neuro-Oncology. 16: 1478-83. PMID 24860178 DOI: 10.1093/Neuonc/Nou097  0.31
2014 Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, Wu Q, Flavahan W, Levison B, Johansen ML, Schmitt D, Neltner JM, Huang P, Ren B, Sloan AE, ... ... Horbinski C, et al. Cancer stem cell-specific scavenger receptor 36 drives glioblastoma progression. Stem Cells (Dayton, Ohio). 32: 1746-58. PMID 24737733 DOI: 10.1002/Stem.1716  0.629
2014 Gilbert MR, Liu Y, Neltner J, Pu H, Morris A, Sunkara M, Pittman T, Kyprianou N, Horbinski C. Autophagy and oxidative stress in gliomas with IDH1 mutations. Acta Neuropathologica. 127: 221-33. PMID 24150401 DOI: 10.1007/S00401-013-1194-6  0.357
2014 Venere M, Crish J, Wu Q, Horbinski C, Rich J, Rosenfeld S. SC-32 * TARGETING PROLIFERATION AND INVASION IN GLIOBLASTOMA VIA MITOTIC KINESINS Neuro-Oncology. 16: v203-v204. DOI: 10.1093/Neuonc/Nou275.31  0.388
2014 Lathia JD, Hale JS, Sloan AE, Gladson CL, Hazen SL, Horbinski C, Rich JN, Brown JM. INTEGRATION OF CANCER STEM CELL MAINTENANCE AND LIPID METABOLISM BY SCAVENGER RECEPTORS Neuro-Oncology. 16: iii17-iii17. DOI: 10.1093/Neuonc/Nou206.62  0.311
2014 Horbinski C, Liu Y, Gilbert MR, Kyprianou N. MUTANT IDH1 SUPPRESSES APOPTOSIS REGULATOR PAR-4 IN GLIOMAS Neuro-Oncology. 16: iii6-iii6. DOI: 10.1093/Neuonc/Nou206.21  0.4
2013 Horbinski C. What do we know about IDH1/2 mutations so far, and how do we use it? Acta Neuropathologica. 125: 621-36. PMID 23512379 DOI: 10.1007/S00401-013-1106-9  0.306
2013 Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, et al. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathology (Zurich, Switzerland). 23: 565-73. PMID 23438035 DOI: 10.1111/Bpa.12043  0.356
2013 Clark KH, Villano JL, Nikiforova MN, Hamilton RL, Horbinski C. 1p/19q testing has no significance in the workup of glioblastomas. Neuropathology and Applied Neurobiology. 39: 706-17. PMID 23363074 DOI: 10.1111/Nan.12031  0.481
2013 Horbinski C. To BRAF or not to BRAF: is that even a question anymore? Journal of Neuropathology and Experimental Neurology. 72: 2-7. PMID 23242278 DOI: 10.1097/Nen.0B013E318279F3Db  0.346
2012 Horbinski C. Something old and something new about molecular diagnostics in gliomas. Surgical Pathology Clinics. 5: 919-939. PMID 23459421 DOI: 10.1016/J.Path.2012.09.001  0.31
2012 Horbinski C, Nikiforova MN, Hagenkord JM, Hamilton RL, Pollack IF. Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas. Neuro-Oncology. 14: 777-89. PMID 22492957 DOI: 10.1093/Neuonc/Nos077  0.545
2012 Hobbs J, Nikiforova MN, Fardo DW, Bortoluzzi S, Cieply K, Hamilton RL, Horbinski C. Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas. The American Journal of Surgical Pathology. 36: 1186-93. PMID 22472960 DOI: 10.1097/Pas.0B013E3182518E12  0.533
2012 Horbinski C, Nikiforova MN, Hobbs J, Bortoluzzi S, Cieply K, Dacic S, Hamilton RL. The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas. Journal of Neuropathology and Experimental Neurology. 71: 73-82. PMID 22157622 DOI: 10.1097/Nen.0B013E318240Fa65  0.476
2012 Liu Y, Komohara Y, Domenick N, Ohno M, Ikeura M, Hamilton RL, Horbinski C, Wang X, Ferrone S, Okada H. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer. Cancer Immunology, Immunotherapy : Cii. 61: 789-801. PMID 22065046 DOI: 10.1007/S00262-011-1137-9  0.502
2012 Horbinski C, Nikiforova MN, Hagenkord J, Hamilton RL, Pollack IF. Abstract 5558: Interplay between BRAF, p16, p53, and MIB1 in pediatric low grade gliomas Cancer Research. 72: 5558-5558. DOI: 10.1158/1538-7445.Am2012-5558  0.541
2012 Gilbert M, Liu Y, Morris A, Sunkara M, Kyprinaou N, Horbinski C. Abstract 4971: The oncometabolite (R)-2-hydroxyglutarate modulates stress-induced caspase activity in glioma cells Cancer Research. 72: 4971-4971. DOI: 10.1158/1538-7445.Am2012-4971  0.35
2011 Horbinski C, Hobbs J, Cieply K, Dacic S, Hamilton RL. EGFR expression stratifies oligodendroglioma behavior. The American Journal of Pathology. 179: 1638-44. PMID 21839716 DOI: 10.1016/J.Ajpath.2011.06.020  0.522
2011 Horbinski C, Kofler J, Yeaney G, Camelo-Piragua S, Venneti S, Louis DN, Perry A, Murdoch G, Nikiforova M. Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas. Brain Pathology (Zurich, Switzerland). 21: 564-74. PMID 21314850 DOI: 10.1111/J.1750-3639.2011.00480.X  0.749
2011 Horbinski C, Miller CR, Perry A. Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade. Brain Pathology (Zurich, Switzerland). 21: 57-73. PMID 21129060 DOI: 10.1111/J.1750-3639.2010.00453.X  0.322
2011 Horbinski C, Dillon D, Pittman T. Low-grade recurrence of a congenital high-grade supratentorial tumor with astrocytic features in the absence of adjuvant therapy. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 31: 286-91. PMID 20880322 DOI: 10.1111/J.1440-1789.2010.01156.X  0.386
2011 Liu Y, Komohara Y, Domenick N, Horbinski C, Hamilton R, Ferrone S, Okada H. Abstract 2439: Association of antigen processing machinery components and CD8+ T-cell infiltration in breast cancer brain metastasis Cancer Research. 71: 2439-2439. DOI: 10.1158/1538-7445.Am2011-2439  0.486
2010 Horbinski C. Practical molecular diagnostics in neuropathology: making a tough job a little easier. Seminars in Diagnostic Pathology. 27: 105-13. PMID 20860314 DOI: 10.1053/J.Semdp.2010.04.001  0.373
2010 Horbinski C, Mojesky C, Kyprianou N. Live free or die: tales of homeless (cells) in cancer. The American Journal of Pathology. 177: 1044-52. PMID 20639456 DOI: 10.2353/Ajpath.2010.091270  0.349
2010 Horbinski C, Pollack IF, Wiley C, Murdoch G. A 10-year old girl with neck pain. Brain Pathology (Zurich, Switzerland). 20: 519-22. PMID 20438474 DOI: 10.1111/j.1750-3639.2009.00365.x  0.416
2010 Horbinski C, Kelly L, Nikiforov YE, Durso MB, Nikiforova MN. Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies. The Journal of Molecular Diagnostics : Jmd. 12: 487-92. PMID 20431032 DOI: 10.2353/Jmoldx.2010.090228  0.354
2010 Horbinski C, Wang G, Wiley CA. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas. International Journal of Clinical and Experimental Pathology. 3: 226-37. PMID 20224722  0.508
2010 Horbinski C, Hamilton RL, Nikiforov Y, Pollack IF. Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Acta Neuropathologica. 119: 641-9. PMID 20044755 DOI: 10.1007/S00401-009-0634-9  0.538
2010 Horbinski C, Hamilton RL, Lovell C, Burnham J, Pollack IF. Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas. Brain Pathology (Zurich, Switzerland). 20: 581-8. PMID 19832838 DOI: 10.1111/J.1750-3639.2009.00336.X  0.536
2009 Horbinski C, Mintz A, Engh J, Lieberman F, Hamilton RL, Park DM. Post-therapeutic changes in the molecular profile of glioblastomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2026. PMID 27964598 DOI: 10.1200/Jco.2009.27.15_Suppl.2026  0.531
2009 Park DM, Prevedello DM, Gardner P, Lee D, Henry S, Snyderman C, Carrau R, Horbinski C, Hamilton RL, Kassam AB. Clival chordoma molecular subtypes and clinical behavior. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 10538. PMID 27963890 DOI: 10.1200/Jco.2009.27.15_Suppl.10538  0.481
2009 Horbinski C, Kofler J, Kelly LM, Murdoch GH, Nikiforova MN. Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues. Journal of Neuropathology and Experimental Neurology. 68: 1319-25. PMID 19915484 DOI: 10.1097/Nen.0B013E3181C391Be  0.523
2009 Horbinski C, Wiley CA. Comparison of telepathology systems in neuropathological intraoperative consultations. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 29: 655-63. PMID 19422534 DOI: 10.1111/J.1440-1789.2009.01022.X  0.494
2009 Horbinski C, Hamilton RL. Application of telepathology for neuropathologic intraoperative consultations. Brain Pathology (Zurich, Switzerland). 19: 317-22. PMID 19290998 DOI: 10.1111/J.1750-3639.2009.00265.X  0.456
2009 Horbinski C, Bartynski WS, Carson-Walter E, Hamilton RL, Tan HP, Cheng S. Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression. Ajnr. American Journal of Neuroradiology. 30: 588-90. PMID 18854444 DOI: 10.3174/Ajnr.A1311  0.473
2009 Horbinski C, Dacic S, McLendon RE, Cieply K, Datto M, Brat DJ, Chu CT. Chordoid glioma: a case report and molecular characterization of five cases. Brain Pathology (Zurich, Switzerland). 19: 439-48. PMID 18652591 DOI: 10.1111/J.1750-3639.2008.00196.X  0.66
2008 Horbinski C, Cieply K, Bejjani GK, McFadden K. Primary intracranial dural-based synovial sarcoma with an unusual SYT fluorescence in situ hybridization pattern. Journal of Neurosurgery. 109: 897-903. PMID 18976081 DOI: 10.3171/Jns/2008/109/11/0897  0.664
2008 Striebel JM, Bhargava R, Horbinski C, Surti U, Dabbs DJ. The equivocally amplified HER2 FISH result on breast core biopsy: indications for further sampling do affect patient management. American Journal of Clinical Pathology. 129: 383-90. PMID 18285260 DOI: 10.1309/Kfkdnk8Cenvn24Vu  0.334
2007 Horbinski C, Fine JL, Medina-Flores R, Yagi Y, Wiley CA. Telepathology for intraoperative neuropathologic consultations at an academic medical center: a 5-year report. Journal of Neuropathology and Experimental Neurology. 66: 750-9. PMID 17882019 DOI: 10.1097/Nen.0B013E318126C179  0.748
2007 Kulich SM, Horbinski C, Patel M, Chu CT. 6-Hydroxydopamine induces mitochondrial ERK activation. Free Radical Biology & Medicine. 43: 372-83. PMID 17602953 DOI: 10.1016/J.Freeradbiomed.2007.04.028  0.733
2007 Zhu JH, Horbinski C, Guo F, Watkins S, Uchiyama Y, Chu CT. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. The American Journal of Pathology. 170: 75-86. PMID 17200184 DOI: 10.2353/Ajpath.2007.060524  0.751
2007 Horbinski C, Wiley C. Molecular Genetic Analysis of Oligodendroglial Tumors Yearbook of Pathology and Laboratory Medicine. 2007: 233-235. DOI: 10.1016/S1077-9108(08)70402-X  0.532
2005 Horbinski C, Chu CT. Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radical Biology & Medicine. 38: 2-11. PMID 15589366 DOI: 10.1016/J.Freeradbiomed.2004.09.030  0.532
2004 Kim WY, Horbinski C, Sigurdson W, Higgins D. Proteasome inhibitors suppress formation of polyglutamine-induced nuclear inclusions in cultured postmitotic neurons. Journal of Neurochemistry. 91: 1044-56. PMID 15569248 DOI: 10.1111/J.1471-4159.2004.02788.X  0.59
2003 Garrick MD, Dolan KG, Horbinski C, Ghio AJ, Higgins D, Porubcin M, Moore EG, Hainsworth LN, Umbreit JN, Conrad ME, Feng L, Lis A, Roth JA, Singleton S, Garrick LM. DMT1: a mammalian transporter for multiple metals. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 16: 41-54. PMID 12572663 DOI: 10.1023/A:1020702213099  0.381
2002 Roth JA, Horbinski C, Higgins D, Lein P, Garrick MD. Mechanisms of manganese-induced rat pheochromocytoma (PC12) cell death and cell differentiation. Neurotoxicology. 23: 147-57. PMID 12224755 DOI: 10.1016/S0161-813X(01)00077-8  0.582
2002 Horbinski C, Stachowiak EK, Chandrasekaran V, Miuzukoshi E, Higgins D, Stachowiak MK. Bone morphogenetic protein-7 stimulates initial dendritic growth in sympathetic neurons through an intracellular fibroblast growth factor signaling pathway. Journal of Neurochemistry. 80: 54-63. PMID 11796743 DOI: 10.1046/J.0022-3042.2001.00657.X  0.418
2001 Dattatreyamurty B, Roux E, Horbinski C, Kaplan PL, Robak LA, Beck HN, Lein P, Higgins D, Chandrasekaran V. Cerebrospinal fluid contains biologically active bone morphogenetic protein-7. Experimental Neurology. 172: 273-81. PMID 11716552 DOI: 10.1006/Exnr.2001.7728  0.567
2001 Guo X, Lin Y, Horbinski C, Drahushuk KM, Kim IJ, Kaplan PL, Lein P, Wang T, Higgins D. Dendritic growth induced by BMP-7 requires Smad1 and proteasome activity. Journal of Neurobiology. 48: 120-30. PMID 11438941 DOI: 10.1002/Neu.1046  0.738
2001 Horbinski C, Stachowiak MK, Higgins D, Finnegan SG. Polyethyleneimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina. Bmc Neuroscience. 2: 2. PMID 11231879 DOI: 10.1186/1471-2202-2-2  0.391
2000 Roth JA, Horbinski C, Feng L, Dolan KG, Higgins D, Garrick MD. Differential localization of divalent metal transporter 1 with and without iron response element in rat PC12 and sympathetic neuronal cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 7595-601. PMID 11027219 DOI: 10.1523/Jneurosci.20-20-07595.2000  0.394
Low-probability matches (unlikely to be authored by this person)
2013 Clark K, Voronovich Z, Horbinski C. How molecular testing can help (and hurt) in the workup of gliomas. American Journal of Clinical Pathology. 139: 275-88. PMID 23429363 DOI: 10.1309/Ajcpfo8Iidnbij8Y  0.298
2016 Zhai L, Genet M, Ladomersky E, Lauing K, Wu M, Binder D, Kim L, Rich J, Horbinski C, James CD, Sosman J, Bloch O, Wainwright D. IMST-39. IDO1 IS PROGNOSTIC FOR GLIOBLASTOMA PATIENT SURVIVAL AND CENTRALLY CORRELATES WITH POTENTLY IMMUNOSUPPRESSIVE MEDIATORS Neuro-Oncology. 18: vi95-vi95. DOI: 10.1093/Neuonc/Now212.395  0.297
2016 Hensley PJ, Zetter D, Horbinski CM, Strup SE, Kyprianou N. Association of Epithelial-Mesenchymal-Transition and Nuclear Cofilin with Advanced Urothelial Cancer. Human Pathology. PMID 27402302 DOI: 10.1016/J.Humpath.2016.06.020  0.292
2010 Horbinski C, Oakley GJ, Cieply K, Mantha GS, Nikiforova MN, Dacic S, Seethala RR. The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas. Archives of Pathology & Laboratory Medicine. 134: 1170-6. PMID 20670138 DOI: 10.1043/2009-0380-Oa.1  0.292
2019 Wu M, Miska J, Xiao T, Zhang P, Kane JR, Balyasnikova IV, Chandler JP, Horbinski CM, Lesniak MS. Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism. Journal of Neuro-Oncology. PMID 30706176 DOI: 10.1007/S11060-019-03110-5  0.292
2015 Martin SK, Pu H, Penticuff JC, Cao Z, Horbinski C, Kyprianou N. Multinucleation and mesenchymal-to-epithelial transition alleviate resistance to combined cabazitaxel and antiandrogen therapy in advanced prostate cancer. Cancer Research. PMID 26645563 DOI: 10.1158/0008-5472.Can-15-2078  0.291
2019 Cheng X, Geng F, Zhong Y, Tian Z, Pan M, Cheng C, Horbinski C, Mo X, Han X, Guo D. CBMT-29. PROMOTING FATTY ACID STORAGE BY DIACYLGLYCEROL-ACYLTRANSFERASE 1 PROTECTS GLIOBLASTOMA AGAINST OXIDATIVE STRESS AND MAINTAINS LIPID HOMEOSTASIS FOR RAPID TUMOR GROWTH Neuro-Oncology. 21: vi39-vi39. DOI: 10.1093/Neuonc/Noz175.151  0.291
2018 D. Eckerdt F, Fischietti M, Horbinski C, James CD, Platanias L. CSIG-15. SLFN5: A REPRESSOR OF INTERFERON-INDUCED SIGNALING THAT STIMULATES GLIOBLASTOMA CELL PROLIFERATION. SURVIVAL RESPONSES IN DIFFERENT XENOGRAFT GLIOBLASTOMA MOUSE MODELS Neuro-Oncology. 20: vi46-vi46. DOI: 10.1093/Neuonc/Noy148.181  0.29
2019 Li YD, Veliceasa D, Lamano JB, Lamano JB, Kaur G, Biyashev D, Horbinski CM, Kruser TJ, Bloch O. Systemic and local immunosuppression in patients with high-grade meningiomas. Cancer Immunology, Immunotherapy : Cii. PMID 31030234 DOI: 10.1007/S00262-019-02342-8  0.29
2013 Burikhanov R, Shrestha-Bhattarai T, Qiu S, Shukla N, Hebbar N, Lele SM, Horbinski C, Rangnekar VM. Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4. Cancer Research. 73: 1011-9. PMID 23204231 DOI: 10.1158/0008-5472.Can-12-3212  0.288
2014 Miller TE, Wang J, Sukhdeo K, Horbinski C, Tesar PJ, Wechsler-Reya RJ, Rich JN. Lgr5 Marks Post-Mitotic, Lineage Restricted Cerebellar Granule Neurons during Postnatal Development. Plos One. 9: e114433. PMID 25493560 DOI: 10.1371/Journal.Pone.0114433  0.288
2015 Swaminathan A, D. Lightner D, Pittman T, Horbinski C, Lee Villano J. Refractory anaplastic astrocytoma responsive to PCV in combination with bevacizumab Case Reports in Clinical Pathology. 2. DOI: 10.5430/Crcp.V2N3P17  0.285
2019 Sonabend A, Dmello C, Chen L, Arrieta VA, Gonzalez E, Robert Kane J, Magnusson L, Braun AH, David James C, Horbinski C, Canney M, Carpentier A, Sottilini F, Desseaux C, Muzzio M, et al. SCIDOT-07. ULTRASOUND DELIVERED ALBUMIN BOUND PACLITAXEL EXTENDS SURVIVAL IN MALIGNANT GLIOMA MODELS AND OUTPERFORMS ULTRASOUND DELIVERED CREMOPHOR PACLITAXEL IN BIO-DISTRIBUTION AND SAFETY Neuro-Oncology. 21: vi273-vi274. DOI: 10.1093/Neuonc/Noz175.1148  0.284
2020 Wicker CA, Takiar V, Suganya R, Arnold SM, Brill YM, Chen L, Horbinski CM, Napier D, Valentino J, Kudrimoti MR, Yu G, Izumi T. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients. Oral Oncology. 111: 104949. PMID 32801084 DOI: 10.1016/J.Oraloncology.2020.104949  0.282
2018 Javier R, Shaikh N, Lesniak MS, Sonabend A, Stupp R, Behdad A, Horbinski C. B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma. Diagnostic Pathology. 13: 37. PMID 29871654 DOI: 10.1186/S13000-018-0717-9  0.281
2012 Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KD. Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathologica. 124: 449-51. PMID 22772980 DOI: 10.1007/S00401-012-1011-7  0.281
2016 Xiong Z, Ampudia-Mesias E, Shaver R, Horbinski CM, Moertel CL, Olin MR. Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy. Immunotherapy. 8: 1059-71. PMID 27485078 DOI: 10.2217/Imt-2016-0033  0.281
2017 Vennneti S, Panwalkar P, Clark J, Ramaswamy V, Hawes D, Yang F, Dunham C, Yip S, Hukin J, Sun Y, Schipper M, Chavez L, Margol A, Pekmezci M, Chung C, ... ... Horbinski CM, et al. PDTM-49. GLOBAL REDUCTION IN H3K27me3, SIMILAR TO H3K27M MUTANT GLIOMAS, IS A MOLECULAR SURROGATE FOR PEDIATRIC POSTERIOR FOSSA- GROUP A EPENDYMOMAS Neuro-Oncology. 19: vi200-vi201. DOI: 10.1093/Neuonc/Nox168.811  0.28
2014 Collazo J, Zhu B, Larkin S, Martin SK, Pu H, Horbinski C, Koochekpour S, Kyprianou N. Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer. Cancer Research. 74: 2362-73. PMID 24509905 DOI: 10.1158/0008-5472.Can-13-3058  0.279
2015 Kofuji S, Warren M, Sumita K, Hirayama A, Ramkissoon A, Malhotra A, Yoshino H, Pater L, Gozal Y, Gogela S, Kendler A, Wise T, Curry R, Warnick R, Wakimoto H, ... ... Horbinski C, et al. CBIO-37DYNAMIC ROLE OF GTP-ENERGY METABOLISM IN GLIOMAGENESIS: DIAGNOSTIC AND THERAPEUTIC APPLICATIONS Neuro-Oncology. 17: v62.4-v62. DOI: 10.1093/Neuonc/Nov209.37  0.279
2019 Huang T, Garcia R, Qi J, Lulla R, Horbinski C, Behdad A, Wadhwani N, Shilatifard A, James C, Saratsis AM. Correction: Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes. Oncotarget. 10: 2788. PMID 31105875 DOI: 10.18632/Oncotarget.26881  0.277
2018 Sanusi OR, Arnaout O, Rahme RJ, Horbinski C, Chandler JP. Surgical Resection And Adjuvant Radiation Therpy In The Treatment Of Skull Base Chordomas. World Neurosurgery. PMID 29545225 DOI: 10.1016/J.Wneu.2018.02.127  0.277
2018 Verhaak R, Consortium G, Aldape K, Amin S, Ashley D, Barnholtz-Sloan J, Bates A, Beroukhim R, Bock C, Brat D, Claus E, Costello J, de Groot J, Finocchiaro G, French P, ... ... Horbinski C, et al. DRES-05. MOLECULAR EVOLUTION OF DIFFUSE GLIOMAS AND THE GLIOMA LONGITUDINAL ANALYSIS CONSORTIUM Neuro-Oncology. 20: vi76-vi76. DOI: 10.1093/Neuonc/Noy148.312  0.276
2016 Unruh D, Mirkov S, James CD, Horbinski C. TMIC-15. MUTANT IDH1 SUPPRESSES THE PROCOAGULANT AND PROMALIGNANT EFFECTS OF TISSUE FACTOR IN GLIOMAS Neuro-Oncology. 18: vi203-vi203. DOI: 10.1093/Neuonc/Now212.855  0.275
2014 Pu H, Horbinski C, Hensley PJ, Matuszak EA, Atkinson T, Kyprianou N. PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis. Carcinogenesis. 35: 2592-601. PMID 25173886 DOI: 10.1093/Carcin/Bgu183  0.273
2017 Wu M, Miska J, Zhang P, Kane JR, Xiao T, Balyasnikova I, Chandler J, Horbinski C, Lesniak M. PATH-44. RACE INFLUENCES PATIENT SURVIVAL IN GLIOMA AND ASSOCIATES WITH GENETIC MARKERS OF RETINOIC ACID METABOLISM Neuro-Oncology. 19: vi180-vi181. DOI: 10.1093/Neuonc/Nox168.734  0.273
2016 Kumthekar P, Ahmed A, Lesniak M, James CD, Horbinski C. TMOD-26. DEVELOPING PATIENT-DERIVED XENOGRAFT MODELS OF METASTATIC CANCER TO THE BRAIN Neuro-Oncology. 18: vi212-vi212. DOI: 10.1093/Neuonc/Now212.896  0.272
2015 Martin SK, Pu H, Horbinski C, Cao Z, Kyprianou N. Abstract 2567: Cabazitaxel chemotherapy targets mitotic kinesins resulting in multi-nucleation of prostate cancer cells: A novel mechanism of cross-resistance with antiandrogens in advanced CRPC Cancer Research. 75: 2567-2567. DOI: 10.1158/1538-7445.Am2015-2567  0.27
2019 Zhai L, Ladomersky E, Lauing KL, Wu M, Scholtens DM, Savoor R, Zhang B, Wu JD, Horbinski C, Lukas RV, Binder DC, Wainwright DA. Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg . (2017). Oncoimmunology. 8: 1548242. PMID 30723577 DOI: 10.1080/2162402X.2018.1548242  0.268
2018 Rosenberg AJ, Wainwright DA, Rademaker A, Galvez C, Genet M, Zhai L, Lauing KL, Mulcahy MF, Hayes JP, Odell DD, Horbinski C, Komanduri S, Tetreault MP, Kim KA, Villaflor VM. Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer. Oncotarget. 9: 23482-23493. PMID 29805749 DOI: 10.18632/Oncotarget.25235  0.266
2000 Roth JA, Horbinski C, Feng L, Dolan KG, Higgins D, Garrick MD. Differential Localization of Divalent Metal Transporter 1 with and without Iron Response Element in Rat PC12 and Sympathetic Neuronal Cells The Journal of Neuroscience. 20: 7595-7601. DOI: 10.1523/JNEUROSCI.20-20-07595.2000  0.265
2018 Katagi H, Zhang A, T. Blyth G, D. Eckerdt F, A. Ozark P, Zou L, He X, E. Loughlin K, Sasaki T, Horbinski C, R. Lulla R, M. Saratsis A, Goldman S, David James C, Shilatifard A, et al. PDTM-42. TARGETED INHIBITION OF BET BROMODOMAIN AND JMJD3 PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA Neuro-Oncology. 20: vi212-vi213. DOI: 10.1093/Neuonc/Noy148.881  0.265
2017 Piunti A, Morgan M, Bartom E, Louis N, He X, Zhang A, Horbinski C, Marshall S, Rendleman E, Takahashi Y, Misharin A, Abshiru N, Lulla R, Saratsis A, Kelleher N, et al. PDTM-28. TARGETED INHIBITION OF EZH2 AND BET BROMODOMAIN PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS Neuro-Oncology. 19: vi196-vi196. DOI: 10.1093/Neuonc/Nox168.792  0.265
2018 Unruh D, Mirkov S, Wray B, Lamano J, Scholtens DM, Sarkaria JN, James CD, Horbinski C. STEM-28. TISSUE FACTOR PROMOTES THE GLIOMA STEM CELL PHENOTYPE, AND IS SUPPRESSED BY MUTANT IDH1 Neuro-Oncology. 20: vi249-vi249. DOI: 10.1093/Neuonc/Noy148.1035  0.265
2016 Ma Q, Plunti A, Saratsis A, Lulla R, Fangusaro JR, Horbinski C, Goldman S, James CD, Shilatifard A, Hashizume R. PDTB-10. INHIBITION OF RADIATION-INDUCED DNA DAMAGE REPAIR MEDIATED CHROMATIN MODIFICATION BY HISTONE H3 DEMETHYLASE INHIBITOR IN PEDIATRIC BRAINSTEM GLIOMA Neuro-Oncology. 18: vi151-vi152. DOI: 10.1093/Neuonc/Now212.630  0.264
2017 Horbinski C, Hartung G, Liu B, Mirkov S, Tangen K, Unruh D, Sarkaria J, Linninger A. TMIC-45. DIFFUSION OF D-2-HYDROXYGLUTARATE FROM IDH1 MUTANT GLIOMAS IN THE BRAIN Neuro-Oncology. 19: vi253-vi253. DOI: 10.1093/Neuonc/Nox168.1033  0.264
2023 Zeng C, Song X, Zhang Z, Cai Q, Cai J, Horbinski C, Hu B, Cheng SY, Zhang W. Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis. Acta Neuropathologica Communications. 11: 133. PMID 37580817 DOI: 10.1186/s40478-023-01619-5  0.263
2015 Schonberg DL, Miller TE, Wu Q, Flavahan WA, Das NK, Hale JS, Hubert CG, Mack SC, Jarrar AM, Karl RT, Rosager AM, Nixon AM, Tesar PJ, Hamerlik P, Kristensen BW, ... Horbinski C, et al. Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. Cancer Cell. 28: 441-55. PMID 26461092 DOI: 10.1016/J.Ccell.2015.09.002  0.263
2018 James CD, Ahmed A, Sonabend A, Horbinski C, Stupp R. CSIG-18. MODELING TEMOZOLOMIDE RESISTANCE WITH GLIOBLASTOMA PATIENT DERIVED XENOGRAFTS Neuro-Oncology. 20: vi46-vi47. DOI: 10.1093/Neuonc/Noy148.184  0.259
2019 Lu X, Sukhanova M, Gao J, Horbinski C, Jennings L, Mao Q, Bigio E, Brat D, Appin C. 4. Molecular characterizations of adult diffuse gliomas by the Oncoscan CNV Plus assay and next-generation sequencing (NGS) Cancer Genetics and Cytogenetics. DOI: 10.1016/J.Cancergen.2019.04.010  0.258
2016 Hasan T, Atashi F, Kim J, Guo D, Park C, Wu M, Dey M, Lesniak M, Horbinski C, Ahmed A. STMC-34. ROLE OF INTERLEUKIN-8/CXCR2 REGULATED EPIGENETIC PLASTICITY IN GBM RECURRENCE Neuro-Oncology. 18: vi189-vi190. DOI: 10.1093/Neuonc/Now212.797  0.258
2021 Kumthekar P, Ko CH, Paunesku T, Dixit K, Sonabend AM, Bloch O, Tate M, Schwartz M, Zuckerman L, Lezon R, Lukas RV, Jovanovic B, McCortney K, Colman H, Chen S, ... ... Horbinski C, et al. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. Science Translational Medicine. 13. PMID 33692132 DOI: 10.1126/scitranslmed.abb3945  0.258
2021 Horbinski C, Xi G, Wang Y, Hashizume R, Gopalakrishnan M, Phillips JJ, Houghton P, James CD, Kalapurakal JA. The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma. Neuro-Oncology Advances. 3: vdab085. PMID 34345820 DOI: 10.1093/noajnl/vdab085  0.257
2019 Zhang DY, Dmello C, Chen L, Arrieta VA, Gonzalez-Buendia E, Kane JR, Magnusson LP, Baran A, James CD, Horbinski C, Carpentier A, Desseaux C, Canney M, Muzzio M, Stupp R, et al. Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31831565 DOI: 10.1158/1078-0432.Ccr-19-2182  0.256
2016 Geng F, Cheng X, Wu X, Yoo JY, Cheng C, Guo JY, Mo X, Ru P, Hurwitz B, Kim S, Otero J, Puduvalli VK, Lefai E, Ma J, Nakano I, ... Horbinski C, et al. Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27281560 DOI: 10.1158/1078-0432.Ccr-15-2973  0.255
2015 Black EP, Romond EH, Chmielecki J, Sun J, Kadamyan V, Chambers MD, Stewart RL, Dressler EVM, Mehdi M, Horbinski C, Massarweh SA. Evaluation of possible linkage between everolimus benefit in estrogen receptor (ER)-positive breast cancer and genomic alterations of the PI3K/AKT/mTOR pathway. Journal of Clinical Oncology. 33: 530-530. DOI: 10.1200/Jco.2015.33.15_Suppl.530  0.255
2018 Huang T, Kwon Kim C, Alvarez A, Pangeni R, Wan X, Xiao S, Shi T, Yang Y, Sastry N, Horbinski C, Lu S, Stupp R, Kessler J, Nishikawa R, Nakano I, et al. CSIG-35. MST4 PHOSPHORYLATION OF ATG4B REGULATES AUTOPHAGIC ACTIVITY, TUMORIGENICITY, AND RADIORESISTANCE IN GLIOBLASTOMA Neuro-Oncology. 20: vi50-vi51. DOI: 10.1093/Neuonc/Noy148.201  0.255
2000 Garrick MD, Horbinski C, Dolan KG, Feng L, Burdo JR, Connor JR, Higgins D, Roth JA. Factors associated with nuclear localization of the ire isoform of dmt1 (nramp2/dct1) Blood. 96: 227a.  0.253
2010 Zhu ML, Horbinski CM, Garzotto M, Qian DZ, Beer TM, Kyprianou N. Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Cancer Research. 70: 7992-8002. PMID 20807808 DOI: 10.1158/0008-5472.Can-10-0585  0.253
2018 Alvarez-Breckenridge C, Stocking J, Lastrapes M, Nayyar N, Gill CM, Bertalan M, Kaplan A, McCabe D, Horbinski C, Zakaria R, Nassiri F, Zadeh G, Alvarez MM, Nahed BV, Curry WT, et al. 218 Divergent Clonal Evolution of Melanoma Brain Metastases in Response to Immunotherapy Neurosurgery. 65: 121-122. DOI: 10.1093/Neuros/Nyy303.218  0.252
2023 Lukas RV, Horbinski C. Glioma Response to IDH Inhibition: Real-World Experience. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 29: 4709-4710. PMID 37738033 DOI: 10.1158/1078-0432.CCR-23-2164  0.251
2014 Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang WX, Wilfred BR, Wang LS, Kukull WA, Nandakumar K, Farman ML, Poon WW, Corrada MM, ... ... Horbinski C, et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathologica. 127: 825-43. PMID 24770881 DOI: 10.1007/S00401-014-1282-2  0.251
2017 Wang XM, Yin SH, DU J, DU ML, Wang PY, Wu J, Horbinski CM, Wu MJ, Zheng HQ, Xu XQ, Shu W, Zhang YJ. Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model. Epidemiology and Infection. 1-10. PMID 28397611 DOI: 10.1017/S0950268817000656  0.25
2014 Convertini P, Shen M, Potter PM, Palacios G, Lagisetti C, de la Grange P, Horbinski C, Fondufe-Mittendorf YN, Webb TR, Stamm S. Sudemycin E influences alternative splicing and changes chromatin modifications. Nucleic Acids Research. 42: 4947-61. PMID 24623796 DOI: 10.1093/Nar/Gku151  0.25
2019 Unruh D, Lamano J, Haider Q, Judkins J, Schwartz M, Li Y, McCortney K, Amidei C, Scholtens D, Horbinski C. Innv-42. Venous Thromboembolism Risk Assessment In Patients With Glioma Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.581  0.249
2018 Alvarez-Breckenridge C, Izar B, Stocking J, Lastrapes M, Nayyar N, Gill C, Bertalan M, Kaplan A, McCabe D, Johnson D, Horbinski C, Zakaria R, Nassiri F, Zadeh G, Fisher D, et al. GENE-18. DIVERGENT CLONAL EVOLUTION OF MELANOMA BRAIN METASTASES DURING TREATMENT WITH IMMUNOTHERAPY Neuro-Oncology. 20: vi106-vi107. DOI: 10.1093/Neuonc/Noy148.444  0.247
2017 He X, Louis N, Hashizume R, Zhang P, Balyasnikova I, Horbinski C, Goldman S. DIPG-36. NOVEL THERAPEUTIC APPROACHES USING NANOLIPOSMAL SN-38 FOR THE TREATMENT OF HUMAN BRAINSTEM GLIOMA Neuro-Oncology. 19: iv13-iv13. DOI: 10.1093/Neuonc/Nox083.051  0.246
2023 Sullivan J, Chandler J, Lesniak M, Tate M, Sonabend A, Kalapurakal J, Horbinski C, Lukas R, Kumthekar P, Sachdev S. Clinical outcomes for pleomorphic xanthoastrocytoma patients: an institutional experience. Research Square. PMID 36778274 DOI: 10.21203/rs.3.rs-2535551/v1  0.246
2022 Zhang Y, Nguyen CC, Zhang NT, Fink NS, John JD, Venkatesh OG, Roe JD, Hoffman SC, Lesniak MS, Wolinsky JP, Horbinski C, Szymaniak BM, Buerki RA, Sosman JA, Shenoy NK, et al. Neurological Applications of Belzutifan in von Hippel Lindau Disease. Neuro-Oncology. PMID 36215167 DOI: 10.1093/neuonc/noac234  0.246
2023 Chen P, Khan F, Lin Y, Ali H, Pang L, Dunterman M, Hsu WH, Frenis K, Rowe RG, Wainwright D, McCortney K, Billingham L, Miska J, Horbinski C, Lesniak M. LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression. Research Square. PMID 37886538 DOI: 10.21203/rs.3.rs-3401154/v1  0.245
2015 Cheng Y, Muroski ME, Petit DC, Mansell R, Vemulkar T, Morshed RA, Han Y, Balyasnikova I, Horbinski C, Huang X, Zhang L, Cowburn RP, Lesniak MS. Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26708022 DOI: 10.1016/J.Jconrel.2015.12.028  0.245
2024 Khan F, Lin Y, Ali H, Pang L, Dunterman M, Hsu WH, Frenis K, Grant Rowe R, Wainwright DA, McCortney K, Billingham LK, Miska J, Horbinski C, Lesniak MS, Chen P. Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression. Nature Communications. 15: 1987. PMID 38443336 DOI: 10.1038/s41467-024-46193-z  0.244
2021 Pituch KC, Zannikou M, Ilut L, Xiao T, Chastkofsky M, Sukhanova M, Bertolino N, Procissi D, Amidei C, Horbinski CM, Aboody KS, James CD, Lesniak MS, Balyasnikova IV. Neural stem cells secreting bispecific T cell engager to induce selective antiglioma activity. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33627401 DOI: 10.1073/pnas.2015800118  0.243
2021 Miska J, Rashidi A, Lee-Chang C, Gao P, Lopez-Rosas A, Zhang P, Burga R, Castro B, Xiao T, Han Y, Hou D, Sampat S, Cordero A, Stoolman JS, Horbinski CM, et al. Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma. Science Advances. 7. PMID 33597238 DOI: 10.1126/sciadv.abc8929  0.243
2016 James CD, Ahmed A, Raizer J, Lesniak M, Horbinski C, Kumthekar P. TMOD-08. PDX MODELING OF RECURRENT GLIOBLASTOMA FOR TESTING SALVAGE THERAPIES Neuro-Oncology. 18: vi208-vi208. DOI: 10.1093/Neuonc/Now212.878  0.243
2019 Kumthekar P, Rademaker A, Ko C, Dixit K, Schwartz MA, Sonabend AM, Sharp L, Lukas RV, Stupp R, Horbinski C, McCortney K, Stegh AH. A phase 0 first-in-human study using NU-0129: A gold base spherical nucleic acid (SNA) nanoconjugate targeting BCL2L12 in recurrent glioblastoma patients. Journal of Clinical Oncology. 37: 3012-3012. DOI: 10.1200/Jco.2019.37.15_Suppl.3012  0.241
2020 Yerneni K, Karras C, Weiss HK, Horbinski CM, Bloch O. Intraventricular adult causing hydrocephalus: A case report. Surgical Neurology International. 11: 202. PMID 32754373 DOI: 10.25259/Sni_363_2020  0.241
2018 Scholtens D, Zewde M, Buss A, James D, Unruh D, Horbinski C. GENE-28. METHYLOMES AND TRANSCRIPTOMES VARY ACROSS IDH1 MUTANT CANCERS Neuro-Oncology. 20: vi109-vi109. DOI: 10.1093/Neuonc/Noy148.454  0.239
2017 Satoshi K, Hirayama A, Sakamoto N, Sumita K, Yoshino H, Warren M, Kawaguchi R, Ozawa T, Onishi N, Wolfe K, Okumura K, Ramkissoon A, Chow LML, Malhotra A, Terakawa J, ... ... Horbinski CM, et al. CBIO-12. GTP METABOLIC SWITCH LEADS TO NUCLEOLAR TRANSFORMATION AND MALIGNANT GROWTH OF GLIOBLASTOMA Neuro-Oncology. 19: vi35-vi35. DOI: 10.1093/Neuonc/Nox168.134  0.239
2017 He X, Louis N, Zhang P, Balyasnikova I, Horbinski C, Goldman S, Hashizume R. Scdt-20. New Therapeutic Approach For Brainstem Glioma: Intranasal Delivery Of Nanoliposomal Sn-38. Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Noy148.876  0.238
2023 Lucas CH, Mirchia K, Seo K, Najem H, Chen W, Zakimi N, Choudhury A, Liu SJ, Phillips J, Magill S, Horbinski C, Solomon D, Perry A, Vasudevan H, Heimberger A, et al. Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. Research Square. PMID 37292686 DOI: 10.21203/rs.3.rs-2921804/v1  0.237
2023 Choudhury A, Cady MA, Lucas CG, Najem H, Phillips JJ, Palikuqi B, Zakimi N, Joseph T, Birrueta JO, Chen WC, Bush NAO, Hervey-Jumper SL, Klein OD, Toedebusch CM, Horbinski CM, et al. NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. Biorxiv : the Preprint Server For Biology. PMID 37503127 DOI: 10.1101/2023.07.10.548456  0.237
2012 Hanaoka BY, Peterson CA, Horbinski C, Crofford LJ. Implications of glucocorticoid therapy in idiopathic inflammatory myopathies. Nature Reviews. Rheumatology. 8: 448-57. PMID 22688888 DOI: 10.1038/Nrrheum.2012.85  0.237
2021 Huang T, Yang Y, Song X, Wan X, Wu B, Sastry N, Horbinski CM, Zeng C, Tiek D, Goenka A, Liu F, Brennan CW, Kessler JA, Stupp R, Nakano I, et al. PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells. Molecular Cell. PMID 33539787 DOI: 10.1016/j.molcel.2021.01.015  0.237
2016 Wang H, Horbinski C, Wu H, Liu Y, Sheng S, Liu J, Weiss H, Stromberg AJ, Wang C. NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data. Nucleic Acids Research. PMID 27471031 DOI: 10.1093/Nar/Gkw677  0.236
2017 Miller TE, Liau B, Wallace LC, Morton A, Xie Q, Dixit D, Factor D, Kim L, Morrow J, Wu Q, Mack S, Hubert C, Paddison PJ, Horbinski C, Bernstein B, et al. GENE-30. TRANSCRIPTION ELONGATION FACTORS REPRESENT IN VIVO CANCER DEPENDENCIES IN GLIOBLASTOMA Neuro-Oncology. 19: vi99-vi99. DOI: 10.1093/Neuonc/Nox168.404  0.236
2020 Chastkofsky MI, Pituch KC, Katagi H, Zannikou M, Ilut L, Xiao T, Han Y, Sonabend AM, Curiel DT, Bonner ER, Nazarian J, Horbinski C, James CD, Saratsis AM, Hashizume R, et al. Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33272983 DOI: 10.1158/1078-0432.CCR-20-1499  0.235
2019 McCord M, Steffens A, Kam K, Javier R, McCortney K, Horbinski C. Path-39. Dna Mismatch Repair Enzyme Immunohistochemistry Is A Rapid, Effective Screening Test For Hypermutated Gliomas Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.635  0.235
2019 Horbinski C. Differences in molecular profiles of glioblastomas according to location. Neuro-Oncology. 21: 4-5. PMID 30445513 DOI: 10.1093/Neuonc/Noy172  0.234
2020 McElroy GS, Reczek CR, Reyfman PA, Mithal DS, Horbinski CM, Chandel NS. NAD+ Regeneration Rescues Lifespan, but Not Ataxia, in a Mouse Model of Brain Mitochondrial Complex I Dysfunction. Cell Metabolism. PMID 32574562 DOI: 10.1016/J.Cmet.2020.06.003  0.234
2017 Louis N, He X, Plunti A, Saratsis A, Lulla R, Fangusaro J, Horbinski C, Goldman S, James D, Shilatifard A, Hashizume R. Dipg-28. Radiation Dna Damage Repair Inhibition By Gsk-J4 Induced Chromatin Compaction In Dipg. Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox083.043  0.233
2020 Tran AN, Horbinski C. Mesenchymal stem-like cells in glioblastoma. Neuro-Oncology. PMID 32785668 DOI: 10.1093/Neuonc/Noaa197  0.232
2019 Tran A, Zhang L, Sahm F, Scholtens D, Horbinski C. Ddis-07. Identification Of Druggable Molecular Targets In Meningioma Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.267  0.232
2019 Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, Bordbar D, Shan D, Samanamud J, Mahajan A, Filip I, Orenbuch R, Goetz M, Yamaguchi JT, Cloney M, ... Horbinski C, et al. Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nature Medicine. PMID 30996326 DOI: 10.1038/S41591-019-0449-8  0.23
2023 Meredith DM, Cooley LD, Dubuc A, Morrissette J, Sussman RT, Nasrallah MP, Rathbun P, Yap KL, Wadhwani N, Bao L, Wolff DJ, Ida C, Sukhanova M, Horbinski C, Jennings LJ, et al. ROS1 alterations as a potential driver of gliomas in infant, pediatric, and adult patients. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 100294. PMID 37532182 DOI: 10.1016/j.modpat.2023.100294  0.229
2013 Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Horbinski C, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174  0.228
2022 Miller JJ, Gonzalez Castro LN, McBrayer S, Weller M, Cloughesy T, Portnow J, Andronesi O, Barnholtz-Sloan JS, Baumert BG, Berger MS, Bi WL, Bindra R, Cahill DP, Chang SM, Costello JF, ... Horbinski C, et al. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-Oncology. PMID 36239925 DOI: 10.1093/neuonc/noac207  0.228
2023 Pang L, Dunterman M, Guo S, Khan F, Liu Y, Taefi E, Bahrami A, Geula C, Hsu WH, Horbinski C, James CD, Chen P. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma. Nature Immunology. PMID 37667051 DOI: 10.1038/s41590-023-01605-y  0.228
2018 Winkel M, Lawton CD, Sanusi OR, Horbinski CM, Dahdaleh NS, Smith ZA. Neuro-surgical considerations for treating IgG4-related disease with rare spinal epidural compression. Surgical Neurology International. 9: 209. PMID 30488007 DOI: 10.4103/Sni.Sni_156_18  0.227
2022 Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, Krishnan SN, Varn FS, Arrieta VA, Gupta P, Ferguson SD, et al. Central nervous system immune interactome is function of cancer lineage, tumor microenvironment and STAT3 expression. Jci Insight. PMID 35316217 DOI: 10.1172/jci.insight.157612  0.226
2008 Horbinski C, Carter EM, Heard PL, Sathanoori M, Hu J, Vockley J, Gunn S, Hale DE, Surti U, Cody JD. Molecular and clinical characterization of a recurrent cryptic unbalanced t(4q;18q) resulting in an 18q deletion and 4q duplication. American Journal of Medical Genetics. Part A. 146: 2898-904. PMID 18932219 DOI: 10.1002/Ajmg.A.32557  0.226
2023 Ghorbani A, Avery LM, Sohaei D, Soosaipillai A, Richer M, Horbinski C, McCortney K, Xu W, Diamandis EP, Prassas I. Discovery of novel glioma serum biomarkers by proximity extension assay. Clinical Proteomics. 20: 12. PMID 36959545 DOI: 10.1186/s12014-023-09400-5  0.226
2023 Sadagopan NS, Nandoliya KR, Youngblood MW, Horbinski CM, Ahrendsen JT, Magill ST. A novel BRAF::PTPRN2 fusion in meningioma: a case report. Acta Neuropathologica Communications. 11: 194. PMID 38066633 DOI: 10.1186/s40478-023-01668-w  0.225
2022 Lauko A, Volovetz J, Turaga SM, Bayik D, Silver DJ, Mitchell K, Mulkearns-Hubert EE, Watson DC, Desai K, Midha M, Hao J, McCortney K, Steffens A, Naik U, Ahluwalia MS, ... ... Horbinski C, et al. SerpinB3 drives cancer stem cell survival in glioblastoma. Cell Reports. 40: 111348. PMID 36103817 DOI: 10.1016/j.celrep.2022.111348  0.225
2022 Youngblood MW, Tran AN, Wang W, An S, Scholtens D, Zhang L, O'Shea K, Pokorny JL, Magill ST, Sachdev S, Lukas RV, Ahmed A, Unruh D, Walshon J, McCortney K, ... ... Horbinski C, et al. Docetaxel Targets Aggressive Methylation Profiles and Serves as a Radiosensitizer in High-Risk Meningiomas. Neuro-Oncology. PMID 35976058 DOI: 10.1093/neuonc/noac206  0.223
2023 Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth J, et al. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 12-20. PMID 36634606 DOI: 10.6004/jnccn.2023.0002  0.223
2013 Neltner J, Horbinski C. A 29 year old woman with acute mental status changes. Brain Pathology (Zurich, Switzerland). 23: 479-82. PMID 23936918 DOI: 10.1111/Bpa.12062  0.223
2023 Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, Wen M, Patel S, Movahed-Ezazi M, Faustin A, Spino-Keeton M, Roberts LG, Maloku E, Drexler SA, Liechty BL, ... ... Horbinski C, et al. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neuro-Oncology Advances. 5: vdad076. PMID 37476329 DOI: 10.1093/noajnl/vdad076  0.222
2016 Geng F, Cheng X, Wu X, Cheng C, Guo JY, Horbinski C, Kaur B, Chakravarti A, Guo D. CBIO-07. LIPID DROPLETS, A NOVEL DIAGNOSTIC BIOMARKER AND METABOLIC TARGET IN GLIOBLASTOMA Neuro-Oncology. 18: vi36-vi36. DOI: 10.1093/Neuonc/Now212.145  0.221
2020 Baisiwala S, Hall RR, Saathoff MR, M Shireman J, Park C, Budhiraja S, Goel C, Warnke L, Hardiman C, Wang JY, McCortney K, Horbinski CM, Ahmed AU. LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma. Cancers. 12. PMID 33255632 DOI: 10.3390/cancers12123505  0.22
2019 Lafay-Cousin L, Bouffet E, Strother D, Rudneva V, Hawkins C, Eberhart C, Horbinski C, Heier L, Souweidane M, Williams-Hughes C, Onar-Thomas A, Billups CA, Fouladi M, Northcott P, Robinson G, et al. Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900845. PMID 31774708 DOI: 10.1200/Jco.19.00845  0.22
2021 Shireman JM, Atashi F, Lee G, Ali ES, Saathoff MR, Park CH, Savchuk S, Baisiwala S, Miska J, Lesniak MS, James CD, Stupp R, Kumthekar P, Horbinski CM, Ben-Sahra I, et al. De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. Brain : a Journal of Neurology. PMID 33855339 DOI: 10.1093/brain/awab020  0.216
2021 Gonzalez-Buendia E, Zhao J, Wang L, Mukherjee S, Zhang D, Arrieta VA, Feldstein E, Kane JR, Kang SJ, Lee-Chang C, Mahajan A, Chen L, Realubit R, Karan C, Magnusson L, ... Horbinski C, et al. TOP2B enzymatic activity on promoters and introns modulates multiple oncogenes in human gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34433651 DOI: 10.1158/1078-0432.CCR-21-0312  0.214
2019 Potts MB, Horbinski CM, Jahromi BS. Rapid development of an aneurysm at the anastomotic site of an STA-MCA bypass: Case report and literature review. World Neurosurgery. PMID 31125771 DOI: 10.1016/J.Wneu.2019.05.108  0.214
2021 Lee-Chang C, Miska J, Hou D, Rashidi A, Zhang P, Burga RA, Jusué-Torres I, Xiao T, Arrieta VA, Zhang DY, Lopez-Rosas A, Han Y, Sonabend AM, Horbinski CM, Stupp R, et al. Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma. The Journal of Experimental Medicine. 218. PMID 32991668 DOI: 10.1084/jem.20200913  0.213
2023 Nabors B, Portnow J, Hattangadi-Gluth J, Horbinski C. NCCN CNS Tumor Guidelines Update for 2023. Neuro-Oncology. PMID 37706665 DOI: 10.1093/neuonc/noad169  0.21
2022 Bollu LR, Bommi PV, Monsen PJ, Zhai L, Lauing KL, Bell A, Kim M, Ladomersky E, Yang X, Platanias LC, Matei DE, Bonini MG, Munshi HG, Hashizume R, Wu JD, ... ... Horbinski C, et al. Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma. Journal of Medicinal Chemistry. PMID 36410047 DOI: 10.1021/acs.jmedchem.2c00771  0.21
2018 Liu J, Murali T, Yu T, Liu C, Sivakumaran TA, Moseley HNB, Zhulin IB, Weiss HL, Durbin EB, Ellingson SR, Liu J, Huang B, Hallahan BJ, Horbinski CM, Hodges K, et al. Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30377206 DOI: 10.1158/1055-9965.Epi-17-0984  0.209
2008 Horbinski C. Notch Pathway Inhibition Depletes Stem-like Cells and Blocks Engraftment in Embryonal Brain Tumors Yearbook of Pathology and Laboratory Medicine. 2008: 233-236. DOI: 10.1016/S1077-9108(08)70679-0  0.208
2023 Stegh AH, Horbinski C, Murnan K. Redox homeostasis and beyond: The role of wild-type Isocitrate Dehydrogenases for the pathogenesis of Glioblastoma. Antioxidants & Redox Signaling. PMID 37132598 DOI: 10.1089/ars.2023.0262  0.206
2021 Zhai L, Bell A, Ladomersky E, Lauing KL, Bollu L, Nguyen B, Genet M, Kim M, Chen P, Mi X, Wu JD, Schipma MJ, Wray B, Griffiths J, Unwin RD, ... ... Horbinski C, et al. Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34479957 DOI: 10.1158/1078-0432.CCR-21-1392  0.205
2023 Youngblood MW, Erson-Omay Z, Li C, Najem H, Coșkun S, Tyrtova E, Montejo JD, Miyagishima DF, Barak T, Nishimura S, Harmancı AS, Clark VE, Duran D, Huttner A, Avşar T, ... ... Horbinski C, et al. Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas. Nature Communications. 14: 6279. PMID 37805627 DOI: 10.1038/s41467-023-41926-y  0.205
2014 Timoney PJ, Clark JD, Frederick PA, Krakauer M, Compton C, Horbinski C, Sokol J, Nunery WR. Foreign Body Granuloma Following Orbital Reconstruction with Porous Polyethylene. Ophthalmic Plastic and Reconstructive Surgery. PMID 25393906 DOI: 10.1097/Iop.0000000000000328  0.204
2016 Huang T, Alvarez A, Pangeni R, Horbinski C, Lu S, James CD, Raizer J, Brenann C, Sulman E, Finocchiaro G, Tan M, Nishikawa R, Lu X, Nakano I, Hu B, et al. CSIG-08. A REGULATORY CIRCUIT OF miR-125b/miR-20b AND Wnt SIGNALING CONTROLS GBM PHENOTYPES THROUGH FZD6-MEDIATED PATHWAYS Neuro-Oncology. 18: vi42-vi42. DOI: 10.1093/Neuonc/Now212.169  0.203
2018 Lafay-Cousin L, Robinson G, Rudneva V, Northcott P, Billups C, Onar-Thomas A, Hawkins C, Eberhart C, Horbinski C, Heier L, Souweidane M, Strother D, Fouladi M, Bouffet E, Gajjar A. MBCL-08. MOLECULAR CHARACTERIZATION OF NODULAR DESMOPLASTIC MEDULLOBLASTOMAS IN YOUNG CHILDREN TREATED ON ACNS1221. A REPORT FROM THE CHILDREN ONCOLOGY GROUP Neuro-Oncology. 20: i118-i119. DOI: 10.1093/Neuonc/Noy059.406  0.198
2022 Bitar M, Chornenkyy Y, Flanagan ME, Steffens A, McCortney K, Horbinski C. The Frequency of Focal Cortical Dysplasia-Like Histologic Features Near Adult-Type Diffuse Gliomas. Journal of Neuropathology and Experimental Neurology. 81: 48-53. PMID 35062028 DOI: 10.1093/jnen/nlab120  0.194
2020 Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, Butowski N, Campian JL, Clark SW, Fabiano AJ, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Horbinski C, Junck L, et al. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 1537-1570. PMID 33152694 DOI: 10.6004/jnccn.2020.0052  0.192
2021 Singer LS, Feldman AZ, Buerki RA, Horbinski CM, Lukas RV, Stupp R. The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results. Chinese Clinical Oncology. PMID 34118826 DOI: 10.21037/cco-21-33  0.191
2021 Singer LS, Feldman AZ, Buerki RA, Horbinski CM, Lukas RV, Stupp R. The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results. Chinese Clinical Oncology. PMID 34118826 DOI: 10.21037/cco-21-33  0.191
2022 Rammohan N, Ho A, Saxena M, Bajaj A, Kruser TJ, Horbinski C, Korutz A, Tate M, Sachdev S. Tumor-associated alterations in white matter connectivity have prognostic significance in MGMT-unmethylated glioblastoma. Journal of Neuro-Oncology. PMID 35525907 DOI: 10.1007/s11060-022-04018-3  0.19
2021 Boudreau CE, Najem H, Ott M, Horbinski C, Fang D, DeRay CM, Levine JM, Curran MA, Heimberger AB. INTRATUMORAL DELIVERY OF STING AGONIST RESULTS IN CLINICAL RESPONSES IN CANINE GLIOBLASTOMA. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34433652 DOI: 10.1158/1078-0432.CCR-21-1914  0.187
2021 Najem H, Marisetty A, Horbinski C, Long J, Huse JT, Glitza Oliva IC, Ferguson SD, Kumthekar PU, Wainwright DA, Chen P, Lesniak MS, Burks JK, Heimberger AB. CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. Frontiers in Immunology. 12: 745893. PMID 34691054 DOI: 10.3389/fimmu.2021.745893  0.185
2018 Hakar MH, Liu BP, Horbinski CM. A 25-Year-Old Male with a Subgaleal Mass. Brain Pathology (Zurich, Switzerland). 28: 435-436. PMID 29740947 DOI: 10.1111/Bpa.12609  0.184
2023 Raleigh D, Chen W, Choudhury A, Youngblood M, Polley MY, Lucas CH, Mirchia K, Maas S, Suwala A, Won M, Bayley J, Harmanci A, Harmanci A, Klisch T, Nguyen M, ... ... Horbinski C, et al. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Research Square. PMID 36993741 DOI: 10.21203/rs.3.rs-2663611/v1  0.18
2021 Fares J, Ahmed AU, Ulasov IV, Sonabend AM, Miska J, Lee-Chang C, Balyasnikova IV, Chandler JP, Portnow J, Tate MC, Kumthekar P, Lukas RV, Grimm SA, Adams AK, Hébert CD, ... ... Horbinski C, et al. Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial. The Lancet. Oncology. PMID 34214495 DOI: 10.1016/S1470-2045(21)00245-X  0.179
2024 Tripathi S, Nathan CL, Tate MC, Horbinski CM, Templer JW, Rosenow JM, Sita TL, James CD, Deneen B, Miller SD, Heimberger AB. The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions. Jci Insight. 9. PMID 38193532 DOI: 10.1172/jci.insight.174753  0.174
2021 Horbinski C, McCortney K, Stupp R. MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas. Neuro-Oncology. 23: 858-860. PMID 33830235 DOI: 10.1093/neuonc/noab039  0.172
2023 Jo J, Diaz M, Horbinski C, Mackman N, Bagley S, Broekman M, Rak J, Perry J, Pabinger I, Key NS, Schiff D. Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review. Neuro-Oncology. PMID 37100086 DOI: 10.1093/neuonc/noad059  0.171
2022 Adekanmbi A, Youngblood MW, Karras CL, Oyetunji EA, Kalapurakal J, Horbinski CM, Najem H, Hill VB, Chandler JP, Heimberger AB, Magill ST, Lukas RV. Clinical Management of Supratentorial Non-Skull Base Meningiomas. Cancers. 14. PMID 36497370 DOI: 10.3390/cancers14235887  0.17
2023 Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci A, Klisch TJ, Nguyen MP, Vasudevan HN, ... ... Horbinski CM, et al. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nature Medicine. PMID 37944590 DOI: 10.1038/s41591-023-02586-z  0.17
2015 Zhou P, Erfani S, Liu Z, Jia C, Chen Y, Xu B, Deng X, Alfáro JE, Chen L, Napier D, Lu M, Huang JA, Liu C, Thibault O, Segal R, ... ... Horbinski C, et al. CD151-'3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion Oncotarget. 6: 29675-29693. DOI: 10.18632/oncotarget.4896  0.167
2015 Horbinski C. Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma. Neuro-Oncology. 17: 478-9. PMID 25605815 DOI: 10.1093/neuonc/nou366  0.163
2023 Zannikou M, Duffy JT, Levine RN, Seblani M, Liu Q, Presser A, Arrieta VA, Chen CJ, Sonabend AM, Horbinski CM, Lee-Chang C, Miska J, Lesniak MS, Gottschalk S, Balyasnikova IV. IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM. Journal For Immunotherapy of Cancer. 11. PMID 36759014 DOI: 10.1136/jitc-2022-006239  0.162
2022 Horbinski C, Berger T, Packer RJ, Wen PY. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours. Nature Reviews. Neurology. PMID 35729337 DOI: 10.1038/s41582-022-00679-w  0.162
2021 Kim M, Ladomersky E, Mozny A, Kocherginsky M, O'Shea K, Reinstein ZZ, Zhai L, Bell A, Lauing KL, Bollu L, Rabin E, Dixit K, Kumthekar P, Platanias LC, Hou L, ... ... Horbinski C, et al. Glioblastoma as an age-related neurological disorder in adults. Neuro-Oncology Advances. 3: vdab125. PMID 34647022 DOI: 10.1093/noajnl/vdab125  0.155
2022 Dajani S, Hill VB, Kalapurakal JA, Horbinski CM, Nesbit EG, Sachdev S, Yalamanchili A, Thomas TO. Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy. Journal of Clinical Medicine. 11. PMID 36233828 DOI: 10.3390/jcm11195961  0.153
2023 Alban TJ, Grabowski MM, Otvos B, Bayik D, Wang W, Zalavadia AH, Makarav V, Troike KM, McGraw M, Rabljenovic A, Lauko A, Neumann CK, Roversi G, Waite KA, Cioffi G, ... ... Horbinski C, et al. The SNP rs755622 is associated with immune activation in glioblastoma. Jci Insight. PMID 37252795 DOI: 10.1172/jci.insight.160024  0.146
2015 Swaminathan A, Lightner DD, Pittman T, Horbinski C, Villano JL. Refractory anaplastic astrocytoma responsive to PCV in combination with bevacizumab. Case Reports in Clinical Pathology. 2: 17-22. PMID 38222924 DOI: 10.5430/crcp.v2n3p17  0.143
2008 Horbinski C. Ionizing Radiation Enhances Matrix Metalloproteinase-2 Secretion and Invasion of Glioma Cells through Src/Epidermal Growth Factor Receptor-Mediated p38/Akt and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways Yearbook of Pathology and Laboratory Medicine. 2008: 231-233. DOI: 10.1016/S1077-9108(08)70678-9  0.14
2023 Romay MC, Knutsen RH, Ma F, Mompeón A, Hernandez GE, Salvador J, Mirkov S, Batra A, Sullivan DP, Procissi D, Buchanan S, Kronquist E, Ferrante EA, Muller WA, Walshon J, ... ... Horbinski C, et al. Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in mice. The Journal of Clinical Investigation. PMID 38015629 DOI: 10.1172/JCI166134  0.128
2022 Dmello C, Sonabend A, Arrieta VA, Zhang DY, Kanojia D, Chen L, Gould A, Zhang J, Kang SJ, Winter J, Horbinski C, Amidei C, Győrffy B, Cordero A, Lee-Chang C, et al. Translocon-associated protein subunit SSR3 determines and predicts susceptibility to paclitaxel in breast cancer and glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35552677 DOI: 10.1158/1078-0432.CCR-21-2563  0.116
2024 Najem H, Arrieta VA, Duffy J, Tripathi S, Zannikou M, Dhiantravan S, Miska J, McCortney K, Steffens A, Walshon J, Lee Chang C, Dahdaleh NS, Sonabend AM, Smith Z, Horbinski CM, et al. Prohibitin Expression in Antigen-Presenting Cells: Implications for Inciting Trigger in CNS IgG4-Related Disease. Annals of Case Reports. 9. PMID 38606301 DOI: 10.29011/2574-7754.101607  0.114
2022 Cheng C, Geng F, Li Z, Zhong Y, Wang H, Cheng X, Zhao Y, Mo X, Horbinski C, Duan W, Chakravarti A, Cheng X, Guo D. Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth. Nature Metabolism. PMID 35534729 DOI: 10.1038/s42255-022-00568-y  0.112
2024 Tripathi S, Najem H, Dussold C, Pacheco S, Miska J, McCortney K, Steffens A, Walshon J, Winkowski D, Cloney M, Ordon M, Gibson W, Kemeny H, Youngblood M, Du R, ... ... Horbinski CM, et al. Cancer-associated fibroblast-secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas. The Journal of Clinical Investigation. 134. PMID 38357919 DOI: 10.1172/JCI176613  0.106
2023 Baskaran AB, Dixit KS, Sonabend AW, Horbinski CM, Abutalib SA, Lukas RV. From the ER to the OR: Initial Evaluation of Primary Central Nervous System Lymphoma. The Neurologist. PMID 37027168 DOI: 10.1097/NRL.0000000000000475  0.1
2023 Goenka A, Song X, Tiek D, Iglesia RP, Lu M, Zeng C, Horbinski C, Zhang W, Hu B, Cheng SY. Oncogenic Long Non-coding RNA LINC02283 Enhances PDGF Receptor A mediated Signaling and Drives Glioblastoma Tumorigenesis. Neuro-Oncology. PMID 36988488 DOI: 10.1093/neuonc/noad065  0.081
2023 Shonka NA, Horbinski CM. Reconciling the Contemporary Molecular Diagnosis of Glioblastoma With Past Clinical Trial Data. Jco Oncology Practice. OP2200784. PMID 36638329 DOI: 10.1200/OP.22.00784  0.08
2021 Horbinski C, Zumpf KB, McCortney K, Eoannou D. Longitudinal observational study of boxing therapy in Parkinson's disease, including adverse impacts of the COVID-19 lockdown. Bmc Neurology. 21: 326. PMID 34429075 DOI: 10.1186/s12883-021-02359-6  0.077
2020 Kam KL, Snuderl M, Khan O, Wolinsky JP, Gondi V, Grimm S, Horbinski C. Using methylation profiling to diagnose systemic metastases of pleomorphic xanthoastrocytoma. Neuro-Oncology Advances. 2: vdz057. PMID 32002518 DOI: 10.1093/noajnl/vdz057  0.077
2021 Horbinski C, Zumpf KB, McCortney K, Eoannou D. Longitudinal Study of Boxing Therapy in Parkinson's Disease, Including Adverse Impacts of the COVID-19 Lockdown. Research Square. PMID 33851151 DOI: 10.21203/rs.3.rs-355283/v1  0.077
2022 Xu D, Bhattacharyya S, Wang W, Ifergan I, Chiang Wong MA, Procissi D, Yeldandi A, Bale S, Marangoni RG, Horbinski C, Miller SD, Varga J. PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multi-organ fibrosis. Jci Insight. PMID 35104243 DOI: 10.1172/jci.insight.151037  0.076
2021 Ramani SL, Samet J, Franz CK, Hsieh C, Nguyen CV, Horbinski C, Deshmukh S. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiology. PMID 33598718 DOI: 10.1007/s00256-021-03734-7  0.071
2021 Larkin CJ, Jennings LJ, Heimberger AB, Horbinski C. Next-Generation Sequencing of a Glioblastoma with True Epithelial Differentiation. Journal of Neuropathology and Experimental Neurology. PMID 34865083 DOI: 10.1093/jnen/nlab114  0.065
2015 Lee TJ, Haque F, Shu D, Yoo JY, Li H, Yokel RA, Horbinski C, Kim TH, Kim SH, Kwon CH, Nakano I, Kaur B, Guo P, Croce CM. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model Oncotarget. 6: 14766-14776.  0.047
2023 Stamm B, DiBiase R, Lee J, Primdahl D, Malavia T, Dixit K, Horbinski C, Kostelecky N, Elhodaky M, Potts MB, Caprio FZ, Bernstein RA, Urday S. A Woman With Multifocal Ischemic Strokes and Progressive Cognitive Impairment due to Intravascular Lymphoma. Stroke. PMID 37534510 DOI: 10.1161/STROKEAHA.123.043934  0.025
2010 Horbinski C. Authors' reply Journal of Neuropathology and Experimental Neurology. 69: 320-321. DOI: 10.1097/01.jnen.0000368767.41938.45  0.016
Hide low-probability matches.